27-33.fm

Similar documents

Journal of Educational Innovation Research 2019, Vol. 29, No. 2, pp DOI: 3 * Effects of 9th

Abstract Background : Most hospitalized children will experience physical pain as well as psychological distress. Painful procedure can increase anxie

Journal of Educational Innovation Research 2018, Vol. 28, No. 1, pp DOI: * A Analysis of

Journal of Educational Innovation Research 2017, Vol. 27, No. 1, pp DOI: * The

< D B4D9C3CAC1A120BCD2C7C1C6AEC4DCC5C3C6AEB7BBC1EEC0C720B3EBBEC8C0C720BDC3B7C2BAB8C1A4BFA120B4EBC7D120C0AFBFEBBCBA20C6F2B0A E687770>

ๆญฏ1.PDF

Lumbar spine

Journal of Educational Innovation Research 2018, Vol. 28, No. 1, pp DOI: * A Study on the Pe

03-ร€รŒรยฆร‡รถ

hwp

04_์ด๊ทผ์›_21~27.hwp

Journal of Educational Innovation Research 2019, Vol. 29, No. 1, pp DOI: (LiD) - - * Way to

Journal of Educational Innovation Research 2019, Vol. 29, No. 1, pp DOI: * Suggestions of Ways

์„œ๋ก  34 2

012์ž„์ˆ˜์ง„

Journal of Educational Innovation Research 2017, Vol. 27, No. 3, pp DOI: (NCS) Method of Con

Journal of Educational Innovation Research 2018, Vol. 28, No. 4, pp DOI: * A S

ํ•œ๊ตญ์„ฑ์ธ์—์„œ์ดˆ๊ธฐํ™ฉ๋ฐ˜๋ณ€์„ฑ์งˆํ™˜๊ณผ ์—ฐ๊ด€๋œ์œ„ํ—˜์š”์ธ์—ฐ๊ตฌ

00์•ฝ์ œ๋ถ€๋ด„ํ˜ธc03้€žํ’š

Kor. J. Aesthet. Cosmetol., ๋ฐ ์ž์•„์กด์ค‘๊ฐ๊ณผ ์ŠคํŠธ๋ ˆ์Šค์™€๋„ ๋ฐ€์ ‘ํ•œ ๊ด€๊ณ„๊ฐ€ ์žˆ๊ณ , ๋งŒ์กฑ ์ •๋„ ์— ๋”ฐ๋ผ ์ „๋ฐ˜์ ์ธ ์ƒํ™œ์—๋„ ์˜ํ–ฅ์„ ๋ฏธ์น˜๋ฏ€๋กœ ์‹ ์ฒด๋Š” ๊ฐˆ์ˆ˜๋ก ๊ฐœ ์ธ์ , ์‚ฌํšŒ์  ์ฐจ์›์—์„œ ์ค‘์š”ํ•ด์ง€๊ณ  ์žˆ๋‹ค(์•ˆํฌ์ง„, 2010). ๋”ฐ๋ผ์„œ ์™ธ๋ชจ๋งŒ์กฑ๋„๋Š” ๊ฐœ์ธ์˜ ์‹ ์ฒด๋Š” ํƒ€

Journal of Educational Innovation Research 2017, Vol. 27, No. 2, pp DOI: : Researc


DBPIA-NURIMEDIA

Journal of Educational Innovation Research 2017, Vol. 27, No. 4, pp DOI: * A Study on Teache

untitled

๊ธฐ๊ด€๊ณ ์œ ์—ฐ๊ตฌ์‚ฌ์—…๊ฒฐ๊ณผ๋ณด๊ณ 

๋‹ฌ์ƒ์‚ฐ์ด ์ดˆ์‚ฐ๋ชจ ๋ถ„๋งŒ์‹œ๊ฐ„์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ โ… . ์„œ ๋ก  โ…ก. ์—ฐ๊ตฌ๋Œ€์ƒ ๋ฐ ๋ฐฉ๋ฒ• ้” ์€ 23) ์˜ ไธน ๆบช ์— ์ตœ์ดˆ๋กœ ๊ธฐ ์žฌ๋œ ์ฒ˜๋ฐฉ์œผ๋กœ, ์— ๋ณต์šฉํ•˜๋ฉด ํ•œ ๋‹คํ•˜์—ฌ ๋‚œ์‚ฐ์˜ ์˜ˆ๋ฐฉ๊ณผ ๋ฐ, ๋“ฑ์— ๋„๋ฆฌ ํ™œ์šฉ๋˜์–ด ์™”๋‹ค. ้” ์€ ์ด ๆฏ’ ํ•˜๊ณ  ๋Š” ็”˜ ่‹ฆ ํ•˜์—ฌ ๆฐฃ, ๆฐฃ ๅฏฌ,, ็ต ์˜ ํšจ๋Šฅ์ด ์žˆ

์ €์ž‘์žํ‘œ์‹œ - ๋น„์˜๋ฆฌ - ๋ณ€๊ฒฝ๊ธˆ์ง€ 2.0 ๋Œ€ํ•œ๋ฏผ๊ตญ ์ด์šฉ์ž๋Š”์•„๋ž˜์˜์กฐ๊ฑด์„๋”ฐ๋ฅด๋Š”๊ฒฝ์šฐ์—ํ•œํ•˜์—ฌ์ž์œ ๋กญ๊ฒŒ ์ด์ €์ž‘๋ฌผ์„๋ณต์ œ, ๋ฐฐํฌ, ์ „์†ก, ์ „์‹œ, ๊ณต์—ฐ๋ฐ๋ฐฉ์†กํ• ์ˆ˜์žˆ์Šต๋‹ˆ๋‹ค. ๋‹ค์Œ๊ณผ๊ฐ™์€์กฐ๊ฑด์„๋”ฐ๋ผ์•ผํ•ฉ๋‹ˆ๋‹ค : ์ €์ž‘์žํ‘œ์‹œ. ๊ท€ํ•˜๋Š”์›์ €์ž‘์ž๋ฅผํ‘œ์‹œํ•˜์—ฌ์•ผํ•ฉ๋‹ˆ๋‹ค. ๋น„์˜๋ฆฌ. ๊ท€ํ•˜๋Š”์ด์ €์ž‘๋ฌผ์„์˜๋ฆฌ๋ชฉ์ ์œผ๋กœ์ด์šฉํ• 

THE JOURNAL OF KOREAN INSTITUTE OF ELECTROMAGNETIC ENGINEERING AND SCIENCE Nov.; 26(11),

Journal of Educational Innovation Research 2016, Vol. 26, No. 2, pp DOI: * Experiences of Af

<C7D1B9CEC1B7BEEEB9AEC7D03631C1FD28C3D6C1BE292E687770>


์ƒ๋‹ดํ•™์—ฐ๊ตฌ,, SPSS 21.0., t,.,,,..,.,.. (Corresponding Author): / / / Tel: /

., (, 2000;, 1993;,,, 1994), () 65, 4 51, (,, ). 33, 4 30, 23 3 (, ) () () 25, (),,,, (,,, 2015b). 1 5,

DBPIA-NURIMEDIA

1..

Journal of Educational Innovation Research 2018, Vol. 28, No. 4, pp DOI: * A Research Trend

Journal of Educational Innovation Research 2018, Vol. 28, No. 3, pp DOI: NCS : * A Study on

(5์ฐจ ํŽธ์ง‘).hwp

DBPIA-NURIMEDIA

ePapyrus PDF Document

Journal of Educational Innovation Research 2016, Vol. 26, No. 2, pp DOI: * The Mediating Eff

Journal of Educational Innovation Research 2017, Vol. 27, No. 3, pp DOI: : A basic research

<C7D1B1B9B1A4B0EDC8ABBAB8C7D0BAB85F31302D31C8A35F32C2F75F E687770>

V28.

<BFACBCBCC0C7BBE7C7D E687770>

,,,.,,,, (, 2013).,.,, (,, 2011). (, 2007;, 2008), (, 2005;,, 2007).,, (,, 2010;, 2010), (2012),,,.. (, 2011:,, 2012). (2007) 26%., (,,, 2011;, 2006;


<30362E20C6EDC1FD2DB0EDBFB5B4EBB4D420BCF6C1A42E687770>

DBPIA-NURIMEDIA

27 2, 17-31, , * ** ***,. K 1 2 2,.,,,.,.,.,,.,. :,,, : 2009/08/19 : 2009/09/09 : 2009/09/30 * 2007 ** *** ( :

Journal of Educational Innovation Research 2017, Vol. 27, No. 2, pp DOI: * Review of Research

.,,,,,,.,,,,.,,,,,, (, 2011)..,,, (, 2009)., (, 2000;, 1993;,,, 1994;, 1995), () 65, 4 51, (,, ). 33, 4 30, (, 201

Journal of Educational Innovation Research 2018, Vol. 28, No. 4, pp DOI: 3 * The Effect of H

Journal of Educational Innovation Research 2019, Vol. 29, No. 1, pp DOI: An Exploratory Stud


139~144 ยฟร€ยฐรธยพร ร„ยง

May 10~ Hotel Inter-Burgo Exco, Daegu Plenary lectures From metabolic syndrome to diabetes Meta-inflammation responsible for the progression fr

ๆญฏkjmh2004v13n1.PDF

03-์„œ์—ฐ์˜ฅ.hwp

09๊น€์ •์‹.PDF

<5B D B3E220C1A634B1C720C1A632C8A320B3EDB9AEC1F628C3D6C1BE292E687770>

DBPIA-NURIMEDIA

WHO ์˜์ƒˆ๋กœ์šด๊ตญ์ œ์žฅ์• ๋ถ„๋ฅ˜ (ICF) ์—๋Œ€ํ•œ์ดํ•ด์™€๊ธฐ๋Šฅ์ ์žฅ์• ๊ฐœ๋…์˜ํ•„์š”์„ฑ ( ํ™ฉ์ˆ˜๊ฒฝ ) ๊Œ™ 127 ๋…ธ๋™์ •์ฑ…์—ฐ๊ตฌ ์ œ 4 ๊ถŒ์ œ 2 ํ˜ธ pp.127~148 c ํ•œ๊ตญ๋…ธ๋™์—ฐ๊ตฌ์› WHO ์˜์ƒˆ๋กœ์šด๊ตญ์ œ์žฅ์• ๋ถ„๋ฅ˜ (ICF) ์—๋Œ€ํ•œ์ดํ•ด์™€๊ธฐ๋Šฅ์ ์žฅ์• ๊ฐœ๋…์˜ํ•„์š”์„ฑํ™ฉ์ˆ˜๊ฒฝ *, (disabi

<32382DC3BBB0A2C0E5BED6C0DA2E687770>

???? 1

DBPIA-NURIMEDIA

Analyses the Contents of Points per a Game and the Difference among Weight Categories after the Revision of Greco-Roman Style Wrestling Rules Han-bong

<5B31362E30332E31315D20C5EBC7D5B0C7B0ADC1F5C1F8BBE7BEF720BEC8B3BB2DB1DDBFAC2E687770>

16(1)-3(๊ตญ๋ฌธ)(p.40-45).fm


ZNMMZTUCJDUV.hwp


Journal of Educational Innovation Research 2018, Vol. 28, No. 1, pp DOI: : A Study on the Ac

:,,.,. 456, 253 ( 89, 164 ), 203 ( 44, 159 ). Cronbach ฮฑ= ,.,,..,,,.,. :,, ( )

์„œ๋ก 

DBPIA-NURIMEDIA



16(2)-7(p ).fm

์—๋„ˆ์ง€๊ฒฝ์ œ์—ฐ๊ตฌ ์ œ13๊ถŒ ์ œ1ํ˜ธ

Journal of Educational Innovation Research 2017, Vol. 27, No. 4, pp DOI: A Study on the Opti

A 617

Jkcs022(89-113).hwp

Journal of Educational Innovation Research 2018, Vol. 28, No. 3, pp DOI: * Strenghening the Cap

[ ์˜์–ด์˜๋ฌธํ•™ ] ์ œ 55 ๊ถŒ 4 ํ˜ธ (2010) ( ) ( ) ( ) 1) Kyuchul Yoon, Ji-Yeon Oh & Sang-Cheol Ahn. Teaching English prosody through English poems with clon

12์ด๋ฌธ๊ทœ

ๆญฏ5-2-13(์ „๋ฏธํฌ์™ธ).PDF

<C7D1B1B9B1B3C0B0B0B3B9DFBFF85FC7D1B1B9B1B3C0B05F3430B1C733C8A35FC5EBC7D5BABB28C3D6C1BE292DC7A5C1F6C6F7C7D42E687770>

Journal of Educational Innovation Research 2017, Vol. 27, No. 1, pp DOI: NCS : G * The Analy

12ยพรˆร‡รถยฐรฆ 1-155T304ยฎยถรณ

(JH)

์ง€๋‚œ 2009๋…„ 11์›” ์• ํ”Œ์˜ ์•„์ดํฐ ์ถœ์‹œ๋กœ ๋Œ€์ค‘ํ™”์— ์ ‘์–ด๋“  ๊ตญ๋‚ด ์Šค๋งˆํŠธํฐ์˜ ์—ญ์‚ฌ๋Š” 4๋…„ ๋งŒ์— โ€˜1์ธ 1์Šค๋งˆํŠธํฐ ์‹œ๋Œ€โ€™๋ฅผ ๋ˆˆ์•ž์— ๋‘๋ฉด์„œ ๋ชจ๋ฐ”์ผ ์ตœ๊ฐ•๊ตญ์˜ ๊ฟˆ์„ ์‹คํ˜„ํ•ด ๊ฐ€๊ณ  ์žˆ๋‹ค

untitled

005์†ก์˜์ผ

Journal of Educational Innovation Research 2019, Vol. 29, No. 1, pp DOI: * The Participant Expe


DBPIA-NURIMEDIA

Kor. J. Aesthet. Cosmetol., ๋ผ์ดํ”„์Šคํƒ€์ผ์€ ๊ฐœ์ธ ์ƒํ™œ์— ์žˆ์–ด ์‹ฌ๋ฆฌ์  ๋ฌธํ™”์  ์‚ฌํšŒ์  ๋ชจ๋“  ์ธก๋ฉด์˜ ์ƒํ™œ๋ฐฉ์‹๊ณผ ์ฐจ์ด ์ „์ฒด๋ฅผ ๋งํ•œ๋‹ค. ์ด๋Ÿฌํ•œ ๋ผ์ดํ”„์Šค ํƒ€์ผ์€ ์‚ฌ๋žŒ์˜ ๋‚ด์žฌ๋œ ๊ฐ€์น˜๊ด€์ด๋‚˜ ์š•๊ตฌ, ํ–‰๋™ ๋ณ€ํ™”๋ฅผ ํŒŒ์•…ํ•˜์—ฌ ์†Œ๋น„ํ–‰๋™๊ณผ ์‹ฌ๋ฆฌ๋ฅผ ์ถ”์ธกํ•  ์ˆ˜ ์žˆ๊ณ , ๊ฐœ์ธ์˜

Transcription:

ํ•œ๊ตญ์ž„์ƒ์•ฝํ•™ํšŒ์ง€์ œ 25 ๊ถŒ์ œ 1 ํ˜ธ Korean J Clin Pharm, Vol. 25, No. 1, 2015 Original Article Korean Journal of Clinical Pharmacy Official Journal of Korean College of Clinical Pharmacy Available online at http://www.kccp.or.kr pissn: 1226-6051 ์•ฝ๊ตญ์™ธ์—์„œํŒ๋งค๋˜๋Š”์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์„ค๋ช…์„œ์˜๋‚œ์ด๋„ํ‰๊ฐ€ ๊น€๋ฝ์˜ ์ด์ธํ–ฅ * ์˜๋‚จ๋Œ€ํ•™๊ต์•ฝํ•™๋Œ€ํ•™ (2015๋…„ 1์›” 13์ผ์ ‘์ˆ˜ 2015๋…„ 3์›” 2์ผ์ˆ˜์ • 2015๋…„ 3์›” 6์ผ์Šน์ธ ) Readability of the Product Labelling Information of Over-The-Counter Pharmaceuticals in Convenience Store Lak Young Kim and Iyn-Hyang Lee* College of Pharmacy, Yeungnam University, Gyeongsan 712-749, South Korea (Received January 13, 2015 Revised March 2, 2015 Accepted March 6, 2015) ABSTRACT Background: Since November 2012, some of over-the-counter (OTC) medications have been sold in convenience store without pharmacist' s supervision. We purposed to examine if the product labels of OTCs provide sufficient information that is appropriate for consumers who may have low health literacy. Methods: We compared the difficulty of words that are utilized in pharmaceutical product labels of interest (intervention) with those in the 6 th grade textbook (control). Pharmaceutical products of interest were comprised of 13 OTCs which have been sold currently in convenience stores. We grouped words into the 4 levels of difficulty based on the Korean Vocabulary Classification for Education, and statistically tested words frequency in each level between OTCs and control. Results: The 13 OTC labels included lay language (easier or equal to language used in primary school) about 10% less; professional language about 10% more ( in all). Labels for analgesics had the longest and most difficult information, followed by common cold preparations, muscle pain relievers as plaster or cataplasma and digestives. Conclusion: The 13 OTC labels might fail to provide appropriate information for safety use by consumers in terms of the difficulty level of words. The improvement of labels of OTC medications and consumer education strategies are called for safety use of OTC medications sold in convenience stores. KEY WORDS: health literacy, medication information, readability, OTC 2008๋…„ 30๋…„์—ฌ๋งŒ์—์ด๋ฃจ์–ด์ง„์ „๊ตญ๊ทœ๋ชจ์˜๊ธฐ์ดˆ๋ฌธํ•ด๋ ฅ์กฐ์‚ฌ์—์„œ์šฐ๋ฆฌ๋‚˜๋ผ์„ฑ์ธ์˜๋น„๋ฌธํ•ด์œจ ( ์ฆ‰, ๋ฌธ๋งน๋ฅ  ) ์ด 1.7% ์—์ด๋ฅด๋Š”๊ฒƒ์œผ๋กœ๋‚˜ํƒ€๋‚ฌ๋‹ค. 1) ์ƒ๊ธฐ๋ณด๊ณ ์„œ๋Š”์šฐ๋ฆฌ๋‚˜๋ผ์„ฑ์ธ์˜๋น„๋ฌธํ•ด์œจ์ด์„ ์ง„๊ตญํ‰๊ท ๋น„๋ฌธํ•ด์œจ 1.4% ๋ณด๋‹ค๋†’์€์ˆ˜์ค€์ด๋ฉฐ, ๋…ผ์˜์˜๋Œ€์ƒ์„๋ฐ˜๋ฌธํ•ด์ž ( ๋‹จ์–ด๋ฅผ์ฝ์„์ˆ˜๋Š”์žˆ์œผ๋‚˜๋ฌธ์žฅ์ดํ•ด๋Šฅ๋ ฅ์€๊ฑฐ์˜์—†์Œ ) ๊นŒ์ง€๋„“ํžˆ๋ฉด๊ทธ๊ทœ๋ชจ๋Š”์ „์ฒด์„ฑ์ธ์˜ 7%, 260๋งŒ๋ช…์—์ด๋ฅผ๊ฒƒ์œผ๋กœ์ถ”์ •๋œ๋‹ค๊ณ ๋ณด๊ณ ํ•˜์˜€๋‹ค. ์ƒ๊ธฐ์กฐ์‚ฌ๋ฅผํ†ตํ•ด์šฐ๋ฆฌ๋‚˜๋ผ์„ฑ์ธ์ธ๊ตฌ์ค‘ 65% ๊ฐ€์ค‘ํ•™์ƒํ‰๊ท ์˜ 70~80% ์ดํ•˜์˜๊ธฐ์ดˆ๋ฌธํ•ด๋ ฅ์„๋ณด์œ ํ•˜๊ณ ์žˆ์Œ๋„๋“œ๋Ÿฌ๋‚ฌ๋‹ค. ์ƒ๊ธฐ๋ณด๊ณ ์„œ์—๋”ฐ๋ฅด๋ฉด๋น„๋ฌธํ•ด์ž๊ฐ€๊ฒช๋Š”์–ด๋ ค์›€์ค‘์ฒซ์งธ๊ฐ€์€ํ–‰์ด๋‚˜๊ด€๊ณต์„œ๋ฅผ์ด์šฉํ•˜๋Š”๊ฒƒ (71%) ์ด์—ˆ๊ณ , ๋‘๋ฒˆ์งธ๊ฐ€์‚ฌ์šฉ์„ค๋ช…์„œ๋‚˜์ฒ˜๋ฐฉ์ „์„๋ชจ๋ฅด๋Š”๊ฒƒ (67%) ์ด์—ˆ๋‹ค. ๋น„๋ฌธํ•ด์ž๊ฐ€์•„๋‹Œ์ผ๋ฐ˜์ ์ธ์„ฑ์ธ์˜๊ฒฝ์šฐ์—๋„์ผ์ƒ์ƒํ™œ์ค‘ ์ „๋ฌธ์šฉ์–ด (48%), ์–ด๋ ค์šดํ•œ์ž์–ด (18%), ์™ธ๋ž˜์–ด / ์™ธ๊ตญ์–ด (18%) ๋ฅผ์ ‘ํ•˜๋ฉด์ดํ•ด์—์–ด๋ ค์›€์„๋Š๋ผ๋Š”๊ฒƒ์œผ๋กœ๋‚˜ํƒ€๋‚ฌ๋‹ค. 1) ์ „๋ฌธ์šฉ์–ด, ์–ด๋ ค์šดํ•œ์ž์–ด, ์™ธ๋ž˜์–ด / ์™ธ๊ตญ์–ด ๋Š”์˜์•ฝํ’ˆ์„ค๋ช…์„œ์˜๋Œ€๋ถ€๋ถ„์„์ฐจ์ง€ํ•˜๋Š”์šฉ์–ด์ž„์€์ฃผ์ง€์˜์‚ฌ์‹ค์ด๋‹ค. 2,3) 2012 ๋…„๋ถ€ํ„ฐ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ 13์ข…์—๋Œ€ํ•ด์•ฝ๊ตญ์™ธํŒ๋งค๋ฅผํ—ˆ์šฉ ( ์•ฝ์‚ฌ๋ฒ•์ œ44์กฐ์˜ 2) ํ•จ์œผ๋กœ์จ, 4) ํ•ด๋‹น์•ฝํ’ˆ์€์†Œ๋น„์ž๊ฐ€์˜์‚ฌ๋‚˜์•ฝ์‚ฌ์˜๋„์›€์—†์ด์ง์ ‘๊ตฌ์ž…ํ•˜์—ฌ์‚ฌ์šฉํ• ์ˆ˜์žˆ๊ฒŒ๋˜์—ˆ๋‹ค. ๋ณด๊ฑด๋‹น๊ตญ์€์•ˆ์ „์„ฑ์„์ตœ์šฐ์„ ์œผ๋กœ๊ณ ๋ คํ•˜์—ฌ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์„์ง€์ •ํ•˜๊ณ ์žˆ์œผ๋‚˜, ์ด๋“ค์˜์•ฝํ’ˆ์—๋Œ€ํ•ด์„œ๋„์œ„ํ•ด์‚ฌ๋ก€๋Š”์ง€์†์ ์œผ๋กœ๋ณด๊ณ ๋˜๊ณ ์žˆ์–ด, 5-7) ์ฃผ์˜๊ฐ€์š”๊ตฌ๋˜๋Š”์‹ค์ •์ด๋‹ค. ์ „๋ฌธ๊ฐ€์˜๋„์›€์ด์—†๋Š”์ƒํ™ฉ์—์„œ์†Œ๋น„์ž๊ฐ€์˜์•ฝํ’ˆ์‚ฌ์šฉ์‹œ์—ํ™œ์šฉํ• ์ˆ˜์žˆ๋Š”์‹ ๋ขฐ์„ฑ์ด๋‹ด๋ณด๋œ๋Œ€ํ‘œ์ ์ธ๋„๊ตฌ๋Š”์˜์•ฝํ’ˆ์„ค๋ช…์„œ์ด๋‹ค. ๋”ฐ๋ผ์„œ, ์˜์•ฝํ’ˆ์„ค๋ช…์„œ์—๋Œ€ํ•œ์†Œ๋น„์ž์˜์ดํ•ด๋Šฅ๋ ฅ *Correspondence to: Iyn-Hyang Lee, College of Pharmacy, Yeungnam University, Gyeongsan 712-749, South Korea Tel: +82-53-810-2829, Fax: +82-53-810-4654 E-mail: leeiynhyang@ynu.ac.kr 27

28 / Korean J Clin Pharm, Vol. 25, No. 1, 2015 ์ดํ•ด๋‹น์•ฝํ’ˆ์„์•ˆ์ „ํ•˜๊ณ ํšจ๊ณผ์ ์œผ๋กœ์‚ฌ์šฉํ•˜๋Š”๋ฐ๊ฒฐ์ •์ ์š”์†Œ๋กœ์ž‘์šฉํ• ๊ฒƒ์ž„์„์‰ฝ๊ฒŒ์ง์ž‘ํ• ์ˆ˜์žˆ๋‹ค. ์ด์™€๊ด€๋ จ๋œ๋…ผ์˜์ฃผ์ œ๊ฐ€๊ฑด๊ฐ•์ •๋ณด์ดํ•ด๋Šฅ๋ ฅ (health literacy) ์œผ๋กœ๊ฑด๊ฐ•์ •๋ณด๋ฅผ์ฝ๊ณ ์ดํ•ดํ•˜๊ณ ํ™œ์šฉํ• ์ˆ˜์žˆ๋Š”๋Šฅ๋ ฅ์ด๋ผ์ •์˜๋œ๋‹ค. 8) ์ตœ๊ทผ๋“ค์–ด, ์น˜๋ฃŒ๊ฒฐ์ •๊ณผ์ •์—ํ™˜์ž์˜๋Šฅ๋™์ ์ฐธ์—ฌ๊ฐ€๊ฐ•์กฐ๋˜๋ฉด์„œ๊ฑด๊ฐ•์ •๋ณด์ดํ•ด๋Šฅ๋ ฅ์ด์น˜๋ฃŒ๊ฒฐ๊ณผ์—๋ฏธ์น˜๋Š”์˜ํ–ฅ์—๋Œ€ํ•œ๊ด€์‹ฌ์ด๊ณ ์กฐ๋˜๊ณ ์žˆ๋‹ค. ๊ฑด๊ฐ•์ •๋ณด์ดํ•ด๋Šฅ๋ ฅ์ด๋‚ฎ์€์‚ฌ๋žŒ์ผ์ˆ˜๋ก๋งŒ์„ฑ์งˆํ™˜๊ด€๋ฆฌ๊ฐ€์ž˜๋˜์ง€์•Š๊ฑฐ๋‚˜, ์•”๊ฒ€์ง„๊ณผ๊ฐ™์€์˜ˆ๋ฐฉ์„์œ„ํ•œํ™œ๋™์—์†Œ๊ทน์ ์ด๊ณ ์Šค์Šค๋กœ์˜๊ฑด๊ฐ•์—๋ถ€์ •์ ์ธ๊ฒฌํ•ด๋ฅผ๊ฐ€์ง€๊ณ ์žˆ๋‹ค๊ณ ์•Œ๋ ค์ง€๊ณ ์žˆ๋‹ค. 9,10) ๋˜ํ•œ, ์ ์ ˆํ•œ์˜์‚ฌ๊ฒฐ์ •์„๋‚ด๋ฆฌ์ง€๋ชปํ•จ์—๋”ฐ๋ผ์˜ˆ๋ฐฉ์ด๊ฐ€๋Šฅํ•œ์งˆํ™˜์ž„์—๋„๋ถˆ๊ตฌํ•˜๊ณ ์˜๋ฃŒ๊ธฐ๊ด€์ด์šฉ์ด๋‚˜์ž…์›์œจ์ด๋†’์•„์ง€๊ณ , ์ฒ˜๋ฐฉ์•ฝํ’ˆ๋ณต์•ฝ๋˜๋Š”๋ณต์•ฝ์„ค๋ช…์—๋Œ€ํ•œ์ดํ•ด๊ฐ€๋‚ฎ์€๊ฒฐ๊ณผ๋กœ์˜์•ฝํ’ˆ๋ถ€์ž‘์šฉ๋นˆ๋„๊ฐ€๋†’์•„์ง€๋ฉฐ, ๊ด€๋ จ์‚ฌ๋ง๋ฅ ์„์ฆ๊ฐ€์‹œ์ผœ์ƒ๋‹นํ•œ์‚ฌํšŒ์ ๋น„์šฉ์ฆ๊ฐ€๋ฅผ์ดˆ๋ž˜ํ•˜๊ณ ์žˆ๋‹ค. 9,11) ๊ตญ๋‚ด์—์„œ๋Š” 2012๋…„ 11์›” 15์ผ์ผ๋ถ€์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์ดํŽธ์˜์ ๋“ฑ์ „๋ฌธ๊ฐ€๊ฐ€์—†๋Š”์žฅ์†Œ์—์„œ์˜ํŒ๋งค๊ฐ€ํ—ˆ์šฉ๋˜์—ˆ๋‹ค. ์‹œํ–‰ 6๊ฐœ์›”ํ›„์‹ค์‹œ๋œ์กฐ์‚ฌ์—๋”ฐ๋ฅด๋ฉด 14.3% ๊ฐ€์•ฝ๊ตญ์™ธํŒ๋งค์†Œ์—์„œํ‰๊ท  2.1ํšŒ์Šค์Šค๋กœ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์„๊ตฌ๋งคํ•œ๊ฒฝํ—˜์ด์žˆ์—ˆ๋‹ค. 12) ๊ตฌ๋งค์—ฐ๋ น์€ 30๋Œ€ (20.8%), 50๋Œ€ (14.9%), 20๋Œ€ (14.5%), 40๋Œ€ (14.0%), ์ง์—…๊ตฐ์œผ๋กœ๋Š”ํ•™์ƒ (20.8%), ์‚ฌ๋ฌด์ง (18.6%) ์˜์ˆœ์ด์—ˆ๋‹ค. 12) ์ด์ฒ˜๋Ÿผ๊ตฌ๋งค๊ณ„์ธต์ด์ •๋ณด์†Œ์™ธ๊ณ„์ธต์œผ๋กœ๊ฐ„์ฃผํ•˜๊ธฐ์–ด๋ ค์šด์ƒํ™ฉ์ž„์—๋„๋ถˆ๊ตฌํ•˜๊ณ ์ตœ๊ทผ๊ตญ๋‚ด์˜ํ•œ์—ฐ๊ตฌ๋Š”์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์ œ๋„์‹œํ–‰ 1๋…„์ด์ง€๋‚œ์‹œ์ ์—์„œ๋„์—ฌ์ „ํ•œ์†Œ๋น„์ž์˜์ธ์‹๋ถ€์กฑ๊ณผ๋ถ€์ž‘์šฉ๋Œ€์ฒ˜๋Šฅ๋ ฅ๋ถ€์กฑ์œผ๋กœ์ธํ•œ์•ˆ์ „์„ฑ์šฐ๋ ค๋ฅผ๋ณด๊ณ ํ•˜๊ณ ์žˆ๋‹ค. 4) ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์˜์•ฝ๊ตญ์™ธํŒ๋งค๊ฐ€ํ—ˆ์šฉ๋จ์œผ๋กœ์จ์˜์•ฝํ’ˆ์„ค๋ช…์„œ์—๋Œ€ํ•œ์†Œ๋น„์ž์ดํ•ด๋„๊ฐ€ํ˜„์•ˆ์ด๋˜์—ˆ์œผ๋‚˜๊ด€๋ จ๋…ผ์˜๋Š”์šฐ๋ฆฌ์‚ฌํšŒ์—์„œ์ถฉ๋ถ„ํžˆ์ด๋ฃจ์–ด์ง€์ง€๋ชปํ•˜๊ณ ์žˆ๋Š”๊ฒƒ์œผ๋กœ์ƒ๊ฐ๋œ๋‹ค. ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์˜์ผ๋ถ€์ธ์•„์„ธํŠธ์•„๋ฏธ๋…ธํŽœ, ๋ถ€๋ฃจํŽœ์„ค๋ช…์„œ์˜๋‚ด์šฉ์„๋ฏธ๊ตญ, ์˜๊ตญ๋“ฑ๊ณผ๋น„๊ตํ•œ์†์„ฑ๊ตฌ ๊ถŒ๊ฒฝํฌ์˜์—ฐ๊ตฌ 13) ์™€์•„์„ธํŠธ์•„๋ฏธ๋…ธํŽœ, ์ข…ํ•ฉ๊ฐ๊ธฐ์•ฝ๊ฐ 1์ข…์—๋Œ€ํ•ด์‹ค์ฆ์ ์ธ์†Œ๋น„์ž๊ฐ€๋…์„ฑ์„ํƒ๊ตฌํ•œ์ด์ธํ–ฅ๋“ฑ์˜์—ฐ๊ตฌ 2) ๊ฐ€๋ณธ์—ฐ๊ตฌ์˜์ฃผ์ œ์™€์ง์ ‘๊ด€๋ จ์ด์žˆ๋Š”์—ฐ๊ตฌ์˜์ „๋ถ€๋ผํ•ด๋„๊ณผ์–ธ์ด์•„๋‹ˆ์—ˆ๋‹ค. ํŠนํžˆ, ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์„ค๋ช…์„œ์—์‚ฌ์šฉ๋œ์–ดํœ˜๋ฅผ๊ตญ์–ด๊ต์œก์šฉ์–ดํœ˜๋‚œ์ด๋„์™€์ ‘๋ชฉํ•˜์—ฌ์œตํ•ฉ์ ์‹œ๊ฐ์—์„œ์‹ค์‹œํ•œ์—ฐ๊ตฌ๋Š”์ด์ธํ–ฅ๋“ฑ์˜์—ฐ๊ตฌ 2) ๊ฐ€์œ ์ผํ–ˆ์œผ๋ฉฐ, ์ด๋งˆ์ €๋„์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์ค‘ 2์ข…์—๊ตญํ•œ๋˜์–ด์žˆ์—ˆ๋‹ค. ์ด์—๋ณธ์—ฐ๊ตฌ๋Š”ํ˜„ํ–‰์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ 13์ข…์˜์„ค๋ช…์„œ์™€์šฐ๋ฆฌ๋‚˜๋ผ์„ฑ์ธ์˜ํ‰๊ท ์ ์ธ๊ฑด๊ฐ•์ •๋ณด์ดํ•ด๋Šฅ๋ ฅ์˜๋ถ€ํ•ฉ์—ฌ๋ถ€๋ฅผ๋ถ„์„ํ•˜์—ฌ๊ธฐ์ดˆ์ž๋ฃŒ๋ฅผ๋งˆ๋ จํ•จ์œผ๋กœ์จ๊ด€๋ จ๋…ผ์˜์˜์‹œ๊ธ‰์„ฑ์„์•Œ๋ฆฌ๋Š”๊ณ„๊ธฐ๋ฅผ๋งˆ๋ จํ•˜๊ณ ์žํ•œ๋‹ค. ์—ฐ๊ตฌ๋ฐฉ๋ฒ• ์—ฐ๊ตฌ์˜์„ค๊ณ„๋ฐ๋Œ€์ƒ๋ณธ์—ฐ๊ตฌ๋Š”์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์˜์„ค๋ช…์„œ์™€์šฐ๋ฆฌ๋‚˜๋ผ์„ฑ์ธ์˜ํ‰๊ท ์ ์ธ๊ฑด๊ฐ•์ •๋ณด์ดํ•ด๋Šฅ๋ ฅ์˜๋ถ€ํ•ฉ์—ฌ๋ถ€๋ฅผ๋ถ„์„ํ•˜๊ธฐ์œ„ํ•ด๋ถ„์„ ๋Œ€์ƒ๊ณผ๋น„๊ต๋Œ€์ƒ์„๊ฐ๊ฐ๋‹ค์Œ๊ณผ๊ฐ™์ด์ •์˜ํ•˜์˜€๋‹ค. ๋ถ„์„๋Œ€์ƒ์€ 2014๋…„ํ˜„ํ–‰์•ฝ์‚ฌ๋ฒ•์—์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์œผ๋กœ์ง€์ •๋˜์–ด์žˆ๋Š”์ œํ’ˆ 13์ข…์ „์ฒด๋ฅผ๋Œ€์ƒ์œผ๋กœํ•˜์˜€๋‹ค. ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ 13์ข…์€๋‹ค์Œ๊ณผ๊ฐ™๋‹ค. - ์†Œํ™”์ œ 4์ข… : ๋ฒ ์•„์ œ์ •, ๋‹ฅํ„ฐ๋ฒ ์•„์ œ์ •, ํ›ผ์Šคํƒˆ๊ณจ๋“œ์ •, ํ›ผ์Šคํƒˆํ”Œ๋Ÿฌ์Šค์ • - ์ข…ํ•ฉ๊ฐ๊ธฐ์•ฝ 2 ์ข… : ํŒ์ฝœ์—์ด๋‚ด๋ณต์•ก, ํŒํ”ผ๋ฆฐํ‹ฐ์ • - ํŒŒ์Šค๋ฅ˜ 2 ์ข… : ์ œ์ผ์ฟจํŒŒํ”„, ์‹ ์‹ ํŒŒ์Šค์•„๋ ‰์Šค - ํ•ด์—ด์ง„ํ†ต์ œ 5 ์ข… : ํƒ€์ด๋ ˆ๋†€์ • 500 mg, ํƒ€์ด๋ ˆ๋†€์ • 160 mg, ์–ด๋ฆฐ์ดํƒ€์ด๋ ˆ๋†€์ • 80 mg, ์–ด๋ฆฐ์ดํƒ€์ด๋ ˆ๋†€ํ˜„ํƒ์•ก, ์–ด๋ฆฐ์ด๋ถ€๋ฃจํŽœ์‹œ๋Ÿฝ ๋น„๊ต๋Œ€์ƒ์œผ๋กœํ˜„์žฌ์‚ฌ์šฉ๋˜๊ณ ์žˆ๋Š”์ดˆ๋“ฑํ•™๊ต 6ํ•™๋…„๊ตญ์–ด๊ต๊ณผ์„œ๋ฅผ์„ ์ •ํ•˜์˜€๋‹ค. ๋น„๊ต๋Œ€์ƒ์˜์„ ์ •์ด์œ ๋Š”์ผ๋ฐ˜๋Œ€์ค‘์„๋Œ€์ƒ์œผ๋กœํ•˜๋Š”์ •๋ณด์˜ํ‰๊ท ์ ์ˆ˜์ค€์ด์ดˆ๋“ฑ 6ํ•™๋…„์ •๋„์ž„์„๋ณด๊ณ ํ•œ์„ ํ–‰์—ฐ๊ตฌ์—๊ทผ๊ฑฐํ•˜์˜€๋‹ค. 2,14) ์–ดํœ˜๋‚œ์ด๋„๊ธฐ์ค€์„ค์ •๋ณธ์—ฐ๊ตฌ์—์„œ๋Š”์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์˜์•ฝํ’ˆ์„ค๋ช…์„œ์—์‚ฌ์šฉ๋œ์–ดํœ˜์˜๋‚œ์ด๋„๋ฅผ์กฐ์‚ฌํ•˜๊ธฐ์œ„ํ•œ๊ธฐ์ค€์„์„ค์ •ํ•˜๊ธฐ์œ„ํ•ด๊น€๊ด‘ํ•ด์˜ ๋“ฑ๊ธ‰๋ณ„๊ตญ์–ด๊ต์œก์šฉ์–ดํœ˜ ์˜๋“ฑ๊ธ‰๋ถ„๋ฅ˜๋ฅผ๊ธฐ์ดˆ๋กœ์‚ผ์•˜๋‹ค. 15) ๊ตญ๋ฆฝ๊ตญ์–ด์›์—๊ฒŒ์‹œ๋œ๋ณด๋‹ค์ตœ๊ทผ์˜์œ ์‚ฌ์—ฐ๊ตฌ๋ฌผ์„๊ฒ€ํ† ํ•ด๋ณด์•˜์œผ๋‚˜๊น€๊ด‘ํ•ด์˜์—ฐ๊ตฌ์—๋น„ํ•ดํฌ๊ด„์„ฑ, ๋ณดํŽธ์„ฑ์ด๋ถ€์กฑํ•˜๋‹ค๋Š”๊ตญ์–ด๊ต์œกํ•™์ „๋ฌธ๊ฐ€์˜์ž๋ฌธ์„๋ฐ›์•„์—ฐ๊ตฌ์—์„œ๋ฐฐ์ œํ•˜์˜€๋‹ค. ๊น€๊ด‘ํ•ด์˜์—ฐ๊ตฌ๋Š”์–ดํœ˜์ •๋ณด์ฒ˜๋ฆฌ์—ฐ๊ตฌ์†Œ ( ์ฃผ ) ๋‚ฑ๋ง 16) ์—์„œ๋ฐ์ดํ„ฐ๋ฒ ์ด์Šคํ™”๋˜์–ด๊ณต๊ฐœ๋˜๋ฉด์„œ๊ทธ๋“ฑ๊ธ‰๋ถ„๋ฅ˜๊ฐ€๋ณด๋‹ค์„ธ๋ถ„ํ™”๋˜์—ˆ๋‹ค. ์ด์—๋ณธ์—ฐ๊ตฌ์—์„œ๋Š”์„ ํ–‰์—ฐ๊ตฌ์™€์˜๋น„๊ต๋“ฑ์ด์šฉ์ดํ•˜๋„๋ก Table 1๊ณผ๊ฐ™์€์–ดํœ˜๋‚œ์ด๋„๊ธฐ์ค€์„์„ค์ •ํ•˜์˜€๋‹ค. 1๋“ฑ๊ธ‰์€์ •๊ทœ๊ต์œก์ด์ „์ˆ˜์ค€์˜์–ดํœ˜, 2๋“ฑ๊ธ‰์€์ดˆ๋“ฑํ•™๊ต์ˆ˜์ค€์˜์–ดํœ˜, 3๋“ฑ๊ธ‰์€์ค‘๊ณ ๋“ฑํ•™๊ต์ˆ˜์ค€์˜์–ดํœ˜, 4๋“ฑ๊ธ‰์€๋Œ€ํ•™์ด์ƒ์ˆ˜์ค€์˜์–ดํœ˜๋ฅผ์˜๋ฏธํ•œ๋‹ค. ์˜์•ฝํ’ˆ์„ค๋ช…์„œ์‚ฌ์šฉ์–ดํœ˜์˜๋“ฑ๊ธ‰๋ณ„๋ถ„๋ฅ˜์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ 13์ข…์˜์˜์•ฝํ’ˆ์„ค๋ช…์„œ๋ฅผํ™•๋ณดํ•˜๊ธฐ์œ„ํ•ด๊ฐ์ œ์•ฝํšŒ์‚ฌ์—ํ˜‘์กฐ๋ฅผ์š”์ฒญํ•˜๊ณ ์•ฝํ•™์ •๋ณด์›์˜๋‚ด์šฉ๊ณผ์‹ํ’ˆ์˜์•ฝํ’ˆ์•ˆ์ „์ฒ˜ ( ์ดํ•˜์‹์•ฝ์ฒ˜ ) ์˜์˜์•ฝํ’ˆ์ „์ž๋ฏผ์›์ฐฝ๊ตฌ ( ์ด์ง€๋“œ๋Ÿญ ) ์—๊ณต Table 1. Level of vocabulary based on the Korean Vocabulary Classification for education. Classification Kim KH s Natmal study 15) database 16) Class 1: Preschool level 1, 2 1 Class 2: Primary school level 3 2, 3, 4 Class 3: Secondary school level 4 5, 6, 7 Class 4: University level or higher 5 or above 8 or above

์•ฝ๊ตญ์™ธ์—์„œํŒ๋งค๋˜๋Š”์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์„ค๋ช…์„œ์˜๋‚œ์ด๋„ํ‰๊ฐ€ / 29 ๊ฐœ๋œ์˜์•ฝํ’ˆ์˜์ œํ’ˆ์ •๋ณด๋ฅผ์ˆ˜์ง‘ํ•˜์˜€๋‹ค. ์‚ผ์ผ์ œ์•ฝ์˜์–ด๋ฆฐ์ด๋ถ€๋ฃจํŽœ์‹œ๋Ÿฝ, ๋™ํ™”์•ฝํ’ˆ์˜ํŒ์ฝœ์—์ด, ํ•œ๋…์ œ์•ฝ์˜ํ›ผ์Šคํƒˆ๊ณจ๋“œ, ํ›ผ์Šคํƒˆํ”Œ๋Ÿฌ์Šค์ •, ์ œ์ผ์•ฝํ’ˆ์˜์ œ์ผ์ฟจํŒŒํ”„๋“ฑ 5์ข…์˜์•ฝํ’ˆ์€์ œ์•ฝํšŒ์‚ฌ์˜ํ˜‘์กฐ๋ฅผ์–ป์–ด์ „์ž๋ฌธ์„œ๋ฅผ๋ฐ›์•„์—ฐ๊ตฌ์—ํ™œ์šฉํ•˜์˜€๋‹ค. ์ œ์•ฝํšŒ์‚ฌ์˜ํ˜‘์กฐ๋˜๋Š”๋‹ต๋ณ€์„๋ฐ›์ง€๋ชปํ•œ 8์ข…์—๋Œ€ํ•ด์„œ๋Š”์ด์ง€๋“œ๋Ÿญ์—๊ณต๊ฐœ๋œ์˜์•ฝํ’ˆ์ œํ’ˆ์ •๋ณด๋ฅผ๋ฐ”ํƒ•์œผ๋กœ์‹ค์ œ์ฒจ๋ถ€๋ฌธ์„œ์™€๋น„๊ตํ•˜์—ฌ๋™์ผ์„ฑ์—ฌ๋ถ€๋ฅผ๊ฒ€์ฆํ•œํ›„์—ฐ๊ตฌ์—ํ™œ์šฉํ•˜์˜€๋‹ค. ์ˆ˜์ง‘๋œ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ 13์ข…์˜์˜์•ฝํ’ˆ์„ค๋ช…์„œํ…์ŠคํŠธํŒŒ์ผ์—๋Œ€ํ•ด์–ดํœ˜์ •๋ณด์ฒ˜๋ฆฌ์—ฐ๊ตฌ์†Œ์˜๋ถ„์„ํ”„๋กœ๊ทธ๋žจ์„์ด์šฉํ•˜์—ฌํ•ต์‹ฌ์–ดํœ˜์˜๋นˆ๋„๋ฅผ์กฐ์‚ฌํ•˜์˜€๋‹ค. ๊ธฐ๊ณ„์ ์œผ๋กœ์ ์šฉ๋ ์ˆ˜๋ฐ–์—์—†๋Š”์ปดํ“จํ„ฐํ”„๋กœ๊ทธ๋žจ์˜ํ•œ๊ณ„๋ฅผ๊ณ ๋ คํ•˜๊ณ ๋ถ„์„์˜๊ธฐ์ค€์„๋ช…ํ™•ํžˆํ•˜๊ธฐ์œ„ํ•ด๋ช‡๊ฐ€์ง€์›์น™์—์˜ํ•ด์˜์•ฝํ’ˆ์„ค๋ช…์„œํ…์ŠคํŠธํŒŒ์ผ์„์‚ฌ์ „์ •๋ฆฌํ•˜์˜€๋‹ค. ์ฒซ์งธ, ๊ทธ๋ฆผ, ํ‘œ๋“ฑ์—๊ธฐ์žฌ๋œ์–ดํœ˜๋Š”๋ถ„์„์—์„œ์ œ์™ธํ•˜์˜€๋‹ค. ๋‘˜์งธ, ์ผ๋ฐ˜์†Œ๋น„์ž์˜์•ฝํ’ˆ์‚ฌ์šฉ์—๋ฏธ์น˜๋Š”์˜ํ–ฅ์€ํฌ์ง€์•Š์Œ์—๋„๋ถˆ๊ตฌํ•˜๊ณ ์‚ฌ์šฉ์–ดํœ˜์˜๋‚œ์ด์ •๋„๋ฅผ๊ณผ๋„ํ•˜๊ฒŒ๋†’์ผ๊ฒƒ์ด์˜ˆ์ƒ๋˜๋Š”์„ฑ๋ถ„ํ•จ๋Ÿ‰์—๋Œ€ํ•œ์ •๋ณด๋Š”๋ถ„์„์—์„œ์ œ์™ธํ•˜์˜€๋‹ค. ์…‹์งธ, ๋™์‚ฌ๋“ฑ์–ด๋ฏธ๊ฐ€๋ณ€ํ™”ํ•˜๋Š”์–ดํœ˜๋Š”ํ‘œ์ค€๊ตญ์–ด๋Œ€์‚ฌ์ „์—์ œ์‹œ๋˜์–ด์žˆ๋Š”๊ธฐ๋ณธํ˜•์œผ๋กœ๋ฐ”๊พธ์–ด๋ถ„์„์—ํฌํ•จํ•˜์˜€๋‹ค. ๋งˆ์ง€๋ง‰์œผ๋กœ์ง€์‹œ์–ด, ์กฐ์‚ฌ, ์—ฐ๊ฒฐ์–ด๋“ฑ์€๋ถ„์„์—์„œ์ œ์™ธํ•˜์˜€๋‹ค. ์ปดํ“จํ„ฐ๋ถ„์„ํ”„๋กœ๊ทธ๋žจ์„ํ†ตํ•ด์–ป์€ 1์ฐจ๊ฒฐ๊ณผ์ค‘๋ถ„์„์˜ค๋ฅ˜๊ฐ€๋‚œ์–ดํœ˜, ์ž„์‹œ์ฒ˜๋ฆฌ์–ดํœ˜ ( ์˜ˆ. ๊ณ ์œ ๋ช…์‚ฌ ), ๋ฏธ๋“ฑ๋ก์–ด๋“ฑ์„๊น€๊ด‘ํ•ด์˜ ๋“ฑ๊ธ‰๋ณ„๊ตญ์–ด๊ต์œก์šฉ์–ดํœ˜ ๋ฅผ์ด์šฉํ•ด์žฌ๋ถ„๋ฅ˜ํ•˜์˜€๋‹ค. ๋™์Œ์ด์˜์–ด์˜๊ฒฝ์šฐ๊ตญ๋ฆฝ๊ตญ์–ด์›์˜ํ‘œ์ค€๊ตญ์–ด๋Œ€์‚ฌ์ „๊ณผ ๋“ฑ๊ธ‰๋ณ„๊ตญ์–ด๊ต์œก์šฉ์–ดํœ˜ ๋ฅผ๋น„๊ต๊ฒ€ํ† ํ•˜์—ฌ์ตœ์ข…๋ถ„๋ฅ˜๋“ฑ๊ธ‰์„์ •ํ•˜์˜€๋‹ค. ๋งŒ์„ฑ์งˆํ™˜๊ณผ๊ฐ™์ด๋งŒ์„ฑ ( ๋‚ฑ๋ง 5๋“ฑ๊ธ‰ )+ ์งˆํ™˜ ( ๋‚ฑ๋ง 4๋“ฑ๊ธ‰ ) ์ฒ˜๋Ÿผ๋‘๋‹จ์–ด๊ฐ€ํ•ฉ์„ฑ๋œํ˜•ํƒœ์˜๋‹จ์–ด๋Š”๋”๋†’์€๋“ฑ๊ธ‰์ธ๋‚ฑ๋ง 5๋“ฑ๊ธ‰์œผ๋กœ๋ถ„๋ฅ˜๋˜๊ณ , ์ตœ์ข…์ ์œผ๋กœ๋ณธ์—ฐ๊ตฌ๊ธฐ์ค€ 3๋“ฑ๊ธ‰์œผ๋กœ๋ถ„๋ฅ˜ํ•˜์˜€๋‹ค. ๊ฐ์˜์•ฝํ’ˆ์„ค๋ช…์„œ์˜์–ดํœ˜๋นˆ๋„๋Š”์ดˆ๋“ฑํ•™๊ต 6ํ•™๋…„๊ตญ์–ด๊ต๊ณผ์„œ์˜์–ดํœ˜๋นˆ๋„์™€๋น„๊ตํ•˜์—ฌ์–ดํœ˜๋‚œ์ด๋„์˜์ ์ •์„ฑ์„๋น„๊ตํ•˜์˜€๋‹ค (Fig. 1). ํ†ต๊ณ„๋ถ„์„๋ถ„์„๋Œ€์ƒ์ธ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์˜์•ฝํ’ˆ์„ค๋ช…์„œ์—์‚ฌ์šฉ๋œ์–ดํœ˜ ์ค‘๋ถ„์„์—์‚ฌ์šฉ๋œ์–ดํœ˜์™€์ œ์™ธ๋ฐ์žฌ๋ถ„๋ฅ˜๋œ์–ดํœ˜์˜๋นˆ๋„๋ฅผ์ œ์‹œํ•˜์˜€๋‹ค. ๋˜ํ•œ, ์น˜๋ฃŒ๊ตฐ๋ณ„๋กœ์ค‘๋ถ„๋ฅ˜ํ•˜์—ฌ๊ฐํŠน์„ฑ์˜์–ดํœ˜๋นˆ๋„์˜ํ‰๊ท ๊ณผํ‘œ์ค€ํŽธ์ฐจ๋ฅผ์ œ์‹œํ•˜์˜€๋‹ค. ๋ถ„์„๋Œ€์ƒ๊ณผ๋น„๊ต๋Œ€์ƒ์—๋Œ€ํ•ด์‚ฌ์šฉ๋œ์–ดํœ˜์˜๋‚œ์ด๋„๋ณ„๋นˆ๋„๋ฐ๋ฐฑ๋ถ„์œจ์„๊ธฐ๋ณธ์ ์ธ๊ธฐ์ˆ ๋ถ„์„์œผ๋กœ์„œ์ œ์‹œํ•˜์˜€๋‹ค. ์–ดํœ˜๋“ฑ๊ธ‰๋ถ„๋ฅ˜์—๋”ฐ๋ผ์ดˆ๋“ฑํ•™๊ต 6 ํ•™๋…„๊ตญ์–ด๊ต๊ณผ์„œ์˜์–ดํœ˜๋‚œ์ด๋„์™€์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ 13์ข…์˜์–ดํœ˜๋ถ„ํฌ๊ฐ€๋‚œ์ด๋„๋“ฑ๊ธ‰๋ณ„๋กœ๋‹ค๋ฅด๊ฒŒ๋‚˜ํƒ€๋‚˜๋Š”์ง€๋ฅผํ†ต๊ณ„์ ์œผ๋กœ๊ฒ€์ฆํ•˜๊ธฐ์œ„ํ•ด chi-squared test์™€ Fisher s exact test๋ฅผ์‹ค์‹œํ•˜์˜€๋‹ค. ํ†ต๊ณ„๋ถ„์„์€ SPSS ver. 20์„์‚ฌ์šฉํ•˜์˜€์œผ๋ฉฐ, ํ†ต๊ณ„์ ์œ ์˜์„ฑ์—ฌ๋ถ€๋Š” p < 0.05๋กœํŒ๋‹จํ•˜์˜€๋‹ค. ์—ฐ๊ตฌ๊ฒฐ๊ณผ ์—ฐ๊ตฌ๋Œ€์ƒํŠน์„ฑ Table 2๋Š”๋ณธ์—ฐ๊ตฌ์˜๋ถ„์„๋Œ€์ƒ์ธ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ 13์ข…์˜์˜์•ฝํ’ˆ์„ค๋ช…์„œ์—๋Œ€ํ•œ๊ธฐ๋ณธ์ •๋ณด๋ฅผ์ •๋ฆฌํ•œ๊ฒƒ์ด๋‹ค. ๊ฐ์˜์•ฝํ’ˆ์„ค๋ช…์„œ๋ฅผ๊ตฌ์„ฑํ•˜๋Š”๋ฌธ์žฅ์˜์ˆ˜๋Š”์†Œํ™”์ œ๋ฅ˜, ํŒŒ์Šค๋ฅ˜๋ฐ์ข…ํ•ฉ๊ฐ๊ธฐ์•ฝ, ํ•ด์—ด์ง„ํ†ต์ œ์ˆœ์œผ๋กœ๋งŽ์•˜๋‹ค. ๊ฐ€์žฅ๋งŽ์€๋ฌธ์žฅ์œผ๋กœ๊ตฌ์„ฑ๋œํ•ด์—ด์ง„ํ†ต์ œ๋Š”ํ‰๊ท  89๊ฐœ์˜๋ฌธ์žฅ์œผ๋กœ์ด๋ฃจ์–ด์ ธ์žˆ์—ˆ๊ณ , ํฌํ•จ๋œ์ œํ’ˆ์ค‘์—๋Š”์–ด๋ฆฐ์ด๋ถ€๋ฃจํŽœ์‹œ๋Ÿฝ์ด 123๊ฐœ์˜๋ฌธ์žฅ์œผ๋กœ๊ตฌ์„ฑ๋˜์–ด๋‹ค๋ฅธํ•ด์—ด์ง„ํ†ต์ œ๋ณด๋‹ค์•ฝ 30% ์ด์ƒ๋งŽ์•˜๋‹ค. ์ข…ํ•ฉ๊ฐ๊ธฐ์•ฝ 2์ข…์€์ƒํ˜ธ๊ฐ„์˜์ฐจ์ด๊ฐ€๋™์ผ์น˜๋ฃŒ๊ตฐ์—์†ํ•จ์—๋„๋ถˆ๊ตฌํ•˜๊ณ ์ œ์ผ์ปธ๋‹ค. ๋ถ„์„๋œ๋‹จ์–ด์ค‘์ œ์™ธ๊ธฐ์ค€ ( ์ง€์‹œ์–ด, ์กฐ์‚ฌ, ์—ฐ๊ฒฐ์–ด๋“ฑ ) ์—ํ•ด๋‹น๋œ๋น„์œจ์ด์•ฝ 30%( ์ตœ์†Œ 27%, ์ตœ๋Œ€ 37%) ๋กœ๋‚˜ํƒ€๋‚ฌ๋‹ค. ์ด๋ฅผ์ œ์™ธํ•˜๊ณ ํฌํ•จ๋œ๋‹จ์–ด์˜๋น„์œจ์€์ตœ์†Œ 63% ์—์„œ์ตœ๋Œ€ 73% ์—์ด๋ฅด๋ €์œผ๋ฉฐ, ์ „์ฒด๋‹จ์–ด์ค‘ 20% ๊ฐ€๋Ÿ‰ ( ์ตœ์†Œ 18%, ์ตœ๋Œ€ 24%) ์€์žฌ๋ถ„๋ฅ˜๊ฐ€ํ•„์š”ํ•˜์˜€๋‹ค. ํ™˜์–ธํ•˜๋ฉด, ์žฌ๋ถ„๋ฅ˜๊ฐ€ํ•„์š”ํ•œ๋‹จ์–ด๋Š”ํฌํ•จ๋‹จ์–ด์˜ 1/3 ์ •๋„์—ํ•ด๋‹นํ•˜์˜€๋‹ค. ํฌํ•จ๋œ๋‹จ์–ด์˜๋น„์œจ์€์น˜๋ฃŒ๊ตฐ๋ณ„๋กœ์œ ์‚ฌํ•˜์˜€๊ณ , ๋‹ค๋ฅธ์น˜๋ฃŒ๊ตฐ์—๋น„ํ•ดํŒŒ์Šค๋ฅ˜์ œํ’ˆ์˜ํฌํ•จ๋‹จ์–ด๋น„์œจ์ด 5% ์ด์ƒ๋‚ฎ์€๊ฒƒ์ด๊ด€์ฐฐ๋˜์—ˆ๋‹ค. ํฌํ•จ๋‹จ์–ด์˜์ ˆ๋Œ€์ˆ˜์น˜๋Š”ํ•ด์—ด์ง„ํ†ต์ œ๊ฐ€๊ฐ€์žฅ๋งŽ์•˜๋‹ค. ํŠนํžˆ์–ด๋ฆฐ์ด๋ถ€๋ฃจํŽœ์‹œ๋Ÿฝ์˜ํฌํ•จ๋‹จ์–ด๊ฐ€ 1631๊ฐœ๋กœ๋‹ค๋ฅธํ•ด์—ด์ง„ํ†ต์ œ๋ณด๋‹ค 2๋ฐฐ์ด์ƒ๋งŽ์•„ํ‰๊ท ์„์ƒ์Šน์‹œํ‚ค๋Š”์š”์ธ์ด์—ˆ๋‹ค. ์–ด๋ฆฐ์ด๋ถ€๋ฃจํŽœ์‹œ๋Ÿฝ์„์ œ์™ธํ•˜๋ฉดํ•ด์—ด์ง„ํ†ต์ œ์ œํ’ˆ์˜ํฌํ•จ๋‹จ์–ด๋Š”์ข…ํ•ฉ๊ฐ๊ธฐ์•ฝ 2์ข…์˜ํฌํ•จ๋‹จ์–ด๋ณด๋‹ค์•ฝ๊ฐ„๋งŽ์€์ •๋„์˜€๋‹ค. ๊ธฐํƒ€ํŒŒ์Šค๋ฅ˜์˜ํฌํ•จ๋‹จ์–ด์ ˆ๋Œ€์ˆ˜์น˜๋Š”์ข…ํ•ฉ๊ฐ๊ธฐ์•ฝ๋ณด๋‹ค์ ˆ๋ฐ˜์ดํ•˜๋กœ์ ์—ˆ๊ณ , ์†Œํ™”์ œ๋ฅ˜๋Š”์ด๋ณด๋‹ค์ ์–ด์„œ 200 ๋‹จ์–ด๋ฅผ๋„˜์ง€์•Š์•˜๋‹ค. Fig. 1. Flowchart of the study. ๋“ฑ๊ธ‰๋ณ„์–ดํœ˜์˜๋นˆ๋„์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ 13์ข…์˜์˜์•ฝํ’ˆ์„ค๋ช…์„œ์—๋Œ€ํ•ด๋“ฑ๊ธ‰๋ณ„์–ดํœ˜์˜๋นˆ๋„๋ฅผ๋ถ„์„ํ•œ๊ฒฐ๊ณผ๋ฅผ Table 3์—์ œ์‹œํ•˜์˜€๋‹ค. ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์˜์•ฝํ’ˆ์„ค๋ช…์„œ๋Š”๋น„๊ต๋Œ€์ƒ์ธ์ดˆ๋“ฑ 6ํ•™๋…„๊ตญ์–ด๊ต๊ณผ์„œ์˜๊ตฌ์„ฑ๊ณผ๋น„๊ตํ–ˆ์„๋•Œํ‰๊ท ์ ์œผ๋กœ 1, 2๋“ฑ๊ธ‰์€์•ฝ 10% ๊ฐ€๋Ÿ‰๋‚ฎ์€๊ตฌ์„ฑ๋น„์œจ์„๋ณด์˜€๊ณ , 3, 4๋“ฑ๊ธ‰์€์•ฝ 10% ๊ฐ€๋Ÿ‰๋†’์€๊ตฌ์„ฑ๋น„์œจ์„

30 / Korean J Clin Pharm, Vol. 25, No. 1, 2015 Table 2. Basic figures of the drug labels included. Therapeutic class Trade name Number of Number of words (%) sentences Overall Excluded Included Reclassification Digestives Doctor Bearse tab. 16 208 64 (31) 144 (69) 40 (19) Bearse tab. 20 259 78 (30) 181 (70) 56 (22) Festal Gold tab. 9 216 64 (30) 152 (70) 50 (23) Festal Plus tab. 9 216 64 (30) 152 (70) 50 (23) Summary of digestives 13.5 ± 5.4 224.8 ± 23.1 67.5 ± 7.0 156.8 ± 16.5 49.0 ± 6.6 Common cold Pancold A soln. 28 993 306 (31) 687(69) 225 (23) remedies Panpyrin T tab. 47 866 263(30) 603 (70) 199 (23) Summary of common cold remedies 37.5 ± 13.4 925 ± 89.8 284.5 ± 30.4 645.0 ± 59.4 212.0 ± 18.4 Muscle pain relievers as Sinsin PAS-RX 31 422 158 (37) 263 (63) 80 (19) plaster or cataplasma Jeil Cool PAP 39 529 186 (35) 343(65) 93 (18) Summary of muscle pain relievers 35.0 ± 5.7 475.5 ± 75.7 172.0 ± 19.8 303.5 ± 55.9 86.5 ± 9.2 Analgesics Brufen syr. for children 123 2,274 643 (28) 1,631(72) 536(24) Children Tyrenol tab. 80 82 1,020 282 (28) 738(72) 205 (20) Children Tyrenol Susp. 84 1,011 283 (28) 728 (72) 178(20) Tylenol tab. 500 78 972 264 (27) 708 (73) 191 (20) Tylenol tab. 160 79 1,059 293 (28) 766 (72) 197 (19) Summary of analgesics 89.2 ± 19.0 1267.2 ± 563.7 353.0 ± 162.5 914.2 ± 401.2 261.4 ± 153.8 Included = Overall - Excluded Mean ± Standard Deviation ๋‚˜ํƒ€๋ƒˆ๋‹ค. ์†Œํ™”์ œ๋ฅ˜๋Š”๋น„๊ต๋Œ€์ƒ์ธ์ดˆ๋“ฑ 6ํ•™๋…„๊ตญ์–ด๊ต๊ณผ์„œ์™€๋น„๊ตํ–ˆ์„๋•Œ 1, 2, 4๋“ฑ๊ธ‰์–ดํœ˜์˜๋นˆ๋„๊ฐ€ 5% ๋‚ด์™ธ, 3๋“ฑ๊ธ‰์–ดํœ˜์˜๋นˆ๋„๊ฐ€ 9% ๊ฐ€๋Ÿ‰๋†’๊ฒŒ๋‚˜ํƒ€๋‚ฌ๋‹ค. ์ข…ํ•ฉ๊ฐ๊ธฐ์•ฝ 2์ข…์€ 1๋“ฑ๊ธ‰์–ดํœ˜์˜๊ตฌ์„ฑ์€๋น„๊ต๋Œ€์ƒ๊ณผ๊ฑฐ์˜์œ ์‚ฌํ–ˆ์œผ๋‚˜, 2, 3, 4๋“ฑ๊ธ‰์–ดํœ˜๊ฐ€๊ฐ๊ฐ 4%, 8%, 7% ๋†’์•˜๋‹ค. ํŒŒ์Šค๋ฅ˜๋Š”์ข…ํ•ฉ๊ฐ๊ธฐ์•ฝ 2์ข…๊ณผ๋Œ€๋™์†Œ์ดํ•œ๋“ฑ๊ธ‰๋ณ„์–ดํœ˜๊ตฌ์„ฑ๋น„์œจ์„๋ณด์—ฌ์ฃผ์—ˆ์œผ๋ฉฐ 3๋“ฑ๊ธ‰์–ดํœ˜๋งŒ 6% ๋กœ์กฐ๊ธˆ๋”๋‚ฎ์€๊ฒƒ์ด๊ด€์ฐฐ๋˜์—ˆ๋‹ค. ํ•ด์—ด์ง„ํ†ต์ œ๋Š”๋น„๊ต๋Œ€์ƒ๊ณผ๋น„๊ตํ–ˆ์„๋•Œ 1๋“ฑ๊ธ‰์–ดํœ˜์˜๊ตฌ์„ฑ๋น„์œจ์ด 13% ๊ฐ€๋Ÿ‰๋‚ฎ์•˜๊ณ , 2๋“ฑ๊ธ‰์–ดํœ˜๋น„์œจ์€ 7%, 3, 4๋“ฑ๊ธ‰์–ดํœ˜๊ตฌ์„ฑ๋น„์œจ์€ 10% ๊ฐ€๋Ÿ‰๋†’์•˜๋‹ค. ๋ชจ๋“ ์—ฐ๊ตฌ๋Œ€์ƒ์˜์•ฝํ’ˆ์„ค๋ช…์„œ์˜๋“ฑ๊ธ‰๋ณ„์–ดํœ˜๋นˆ๋„๋Š”๋น„๊ต๋Œ€์ƒ์ธ์ดˆ๋“ฑ 6ํ•™๋…„๊ตญ์–ด๊ต๊ณผ์„œ์˜์–ดํœ˜๋นˆ๋„์™€ํ†ต๊ณ„์ ์œผ๋กœ์œ ์˜ํ•˜๊ฒŒ๋‹ค๋ฅธ๊ตฌ์„ฑ์„๋ณด์ด๋Š”๊ฒƒ์„ํ™•์ธํ• ์ˆ˜์žˆ์—ˆ๋‹ค () (Table 3). ๊ณ ์ฐฐ ๋ณธ์—ฐ๊ตฌ๋Š”์†Œ๋น„์ž๋“ค์ด์˜์•ฝ์ „๋ฌธ๊ฐ€์˜๋„์›€์„๋ฐ›์ง€์•Š๊ณ ๊ตฌ๋งคํ• ์ˆ˜์žˆ๋Š”์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ 13์ข…์˜์˜์•ฝํ’ˆ์„ค๋ช…์„œ์—๋Œ€ํ•œํ‰๊ท ์ ์ธ๋ฌธํ•ด๋ ฅ์„๊ฐ€์ง„๊ตญ๋‚ด์†Œ๋น„์ž์˜์ดํ•ด๊ฐ€๋Šฅ์„ฑ์„์‚ฌ์šฉ๋œ์–ดํœ˜๋ฅผ๋ถ„์„ํ•จ์œผ๋กœ์จ์˜ˆ์ธกํ•ด๋ณด์•˜๋‹ค. ์—ฐ๊ตฌ๊ฒฐ๊ณผ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์˜์˜์•ฝํ’ˆ์„ค๋ช…์„œ์—์‚ฌ์šฉ๋œ์–ดํœ˜๋Š”์ผ๋ฐ˜์ธ์˜ํ‰๊ท ์ˆ˜์ค€์œผ๋กœ๊ฐ€์ •ํ•œ์ดˆ๋“ฑ 6ํ•™๋…„๊ตญ์–ด๊ต๊ณผ์„œ์˜์–ดํœ˜๋‚œ์ด๋„์—๋น„ํ•ด์–ด๋ ค์šด๊ฒƒ์œผ๋กœ๋‚˜ํƒ€๋‚ฌ๋‹ค. ๋Œ€์ฒด์ ์œผ๋กœ์ดˆ๋“ฑํ•™์ƒ์ดํ•˜์ˆ˜์ค€์˜์–ดํœ˜๋Š” 10% ๊ฐ€๋Ÿ‰๋‚ฎ์€๊ตฌ์„ฑ๋น„์œจ์„๋ณด์ด๋Š”๋ฐ˜๋ฉด, ์ค‘๋“ฑ์ˆ˜์ค€๋˜๋Š”๋Œ€ํ•™์ˆ˜์ค€์ด์ƒ์˜์ „๋ฌธ์ ์–ดํœ˜๋Š” 10% ๊ฐ€๋Ÿ‰๋†’์€๊ตฌ์„ฑ๋น„์œจ์„๋‚˜ํƒ€๋ƒˆ๋‹ค. ํŠนํžˆ, ๋ถ€์ž‘์šฉ๋ณด๊ณ ์œจ์ด๋†’์•„์•ˆ์ „์„ฑ๋…ผ๋ž€์ด์ ์ฐจ์ปค์ง€๊ณ ์žˆ๋Š”ํ•ด์—ด์ง„ํ†ต์ œ์™€์ข…ํ•ฉ๊ฐ๊ธฐ์•ฝ์ด 5-7) ์†Œํ™”์ œ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ๋ณด๋‹ค๋Œ€ํ•™์ˆ˜์ค€์ด์ƒ (Level 4) ์˜์ „๋ฌธ์–ดํœ˜๋ฅผํ‰๊ท  2~3๋ฐฐ๋”๋งŽ์ดํฌํ•จํ•˜๊ณ ์žˆ์—ˆ๋‹ค. ํŒŒ์Šค๋ฅ˜๋Š”์ข…ํ•ฉ๊ฐ๊ธฐ์•ฝ๊ณผ์œ ์‚ฌํ•œ์ˆ˜์ค€์„๋ณด์˜€๋‹ค. ๋ณธ์—ฐ๊ตฌ์˜๊ฒฐ๊ณผ๋ฅผ์•„์„ธํŠธ์•„๋ฏธ๋…ธํŽœ 650 mg ์„œ๋ฐฉ์ •์—๋Œ€ํ•ด์œ ์‚ฌํ•œ๋ถ„์„์„์‹ค์‹œํ•œ์„ ํ–‰์—ฐ๊ตฌ 2) ์™€๋น„๊ตํ•˜๋ฉด์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์˜์•ฝํ’ˆ์„ค๋ช…์„œ๊ฐ€๋Œ€ํ•™์ˆ˜์ค€์ด์ƒ์ „๋ฌธ์–ดํœ˜๋ฅผ 30% ๊ฐ€๋Ÿ‰์ ๊ฒŒํฌํ•จํ•˜๋Š”๊ฒƒ์œผ๋กœ๋‚˜ํƒ€๋‚ฌ๋‹ค. ์ด๋Ÿฌํ•œ๊ฒฐ๊ณผ๋Š”์„ ํ–‰์—ฐ๊ตฌ๊ฐ€๋ถ„์„์˜๋Œ€์ƒ์„์˜์•ฝํ’ˆ์„ค๋ช…์„œ์ค‘๋ณต์šฉ์ƒ์ฃผ์˜์‚ฌํ•ญ์œผ๋กœ๊ตญํ•œํ•œ์ ์ด์ฃผ์š”์ธ์ธ๊ฒƒ์œผ๋กœ์ƒ๊ฐ๋œ๋‹ค. ๋ณต์šฉ์ƒ์ฃผ์˜์‚ฌํ•ญ์ด์˜์•ฝํ’ˆ์„ค๋ช…์„œ์ค‘์ „๋ฌธ์–ดํœ˜๊ฐ€๊ฐ€์žฅ๋งŽ์ด์‚ฌ์šฉ๋˜๋Š”๋ถ€๋ถ„์ธ๋ฐ๋ฐ˜ํ•ด์ „์ฒด์–ดํœ˜์ˆ˜ ( ๋ถ„๋ชจ ) ๋Š” 1/3 ์ •๋„๋กœ์ค„์–ด์ƒ๋Œ€์ ์œผ๋กœ์ „๋ฌธ์–ดํœ˜์˜๊ตฌ์„ฑ๋น„์œจ์ด๋†’๊ฒŒ๋‚˜ํƒ€๋‚œ๊ฒƒ์ด๋‹ค. ์˜์•ฝํ’ˆ์„ค๋ช…์„œ์ค‘๋ณต์šฉ์ƒ์ฃผ์˜์‚ฌํ•ญ๋ถ€๋ถ„์ด์˜์•ฝํ’ˆ์•ˆ์ „์‚ฌ์šฉ๊ณผ๊ด€๋ จํ•˜์—ฌ๊ฐ€์žฅํ•ต์‹ฌ์ ์ธ์ •๋ณด๋ฅผ๋‹ด๊ณ ์žˆ๋Š”๊ฒƒ์„์ƒ๊ฐํ• ๋•Œ๋ณธ์—ฐ๊ตฌ์™€์„ ํ–‰์—ฐ๊ตฌ์ฐจ์ด๋Š”์ผ๋ฐ˜์†Œ๋น„์ž๊ฐ€์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์—๋™๋ด‰๋œ์˜์•ฝํ’ˆ์„ค๋ช…์„œ๋ฅผ์ด์šฉํ•˜์—ฌํ•ด๋‹น์˜์•ฝํ’ˆ์„๋ณต์šฉํ•˜๊ณ ์žํ• ๋•Œ๊ฒช๋Š”์–ด๋ ค์›€์ด๋ณธ์—ฐ๊ตฌ๊ฒฐ๊ณผ์—์„œ๋‹ค์†Œ๊ณผ์†Œํ‰๊ฐ€๋˜์—ˆ์„์ˆ˜์žˆ๋‹ค๋Š”์ ์„์‹œ์‚ฌํ•œ๋‹ค. ๋น„๋ก, ์•ฝ์‚ฌ๋ฒ• ์ œ59์กฐ์—๋Š”์˜์•ฝํ’ˆ์˜์šฉ๊ธฐ๋‚˜ํฌ์žฅ๋˜๋Š”์ฒจ๋ถ€๋ฌธ์„œ์—ํ‘œ์‹œ์‚ฌํ•ญ์„๊ธฐ์žฌํ• ๊ฒฝ์šฐ๋‹ค๋ฅธ๋ฌธ์ž, ๊ธฐ์‚ฌ, ๊ทธ๋ฆผ๋˜๋Š”๋„์•ˆ๋ณด๋‹ค์‰ฝ๊ฒŒ๋ณผ์ˆ˜์žˆ๋Š”๋ถ€๋ถ„์—, ์•Œ๊ธฐ์‰ฝ๊ณ ์ดํ•ดํ•˜๊ธฐ์‰ฌ์šด์šฉ์–ด

์•ฝ๊ตญ์™ธ์—์„œํŒ๋งค๋˜๋Š”์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์„ค๋ช…์„œ์˜๋‚œ์ด๋„ํ‰๊ฐ€ / 31 Table 3. Number of words by level. Group Control: 6 th grade textbook (Korean) Over-the-counter drugs: labels Digestives Common cold remedies Muscle pain reliever as plaster or cataplasma Analgesics Number of words (%) Level 1 Level 2 Level 3 Level 4 Overall 8142 (44.1) 193 (35.3) 61 (39.0) Doctor Bearse 46 tab. (31.9) Bearse tab. 67 (37.0) Festal Gold tab. 66 (43.4) Festal Plus tab. 66 (43.4) 280 (43.3) Pancold A soln. 294 (42.8) Panpyrin T tab. 265 (43.9) 135 (44.3) Sinsin PAS-RX 138 (52.3) Jeil Cool PAP 131 (38.2) 286 (31.3) Brufen syr. for 476 children (29.2) Children Tyrenol 239 tab. 80 (32.4) Children Tyrenol 239 Susp. (32.8) Tylenol tab. 500 232 (32.8) Tylenol tab. 160 246 (32.1) 9511 (51.6) 235 (43.0) 71 (44.8) 69 (47.9) 75 (41.4) 69 (45.4) 69 (45.4) 240 (37.2) 263 (38.3) 217 (36.0) 117 (38.4) 90 (34.1) 143 (41.7) 411 (45.0) 681 (41.8) 349 (47.3) 342 (47.0) 324 (45.8) 360 (47.0) 619 (3.4) 67 (12.3) 20 (12.4) 24 (16.7) 26 (14.4) 14 (9.2) 14 (9.2) 75 (11.6) 76 (11.1) 74 (12.3) 30 (9.7) 24 (9.1) 35 (10.2) 117 (12.8) 241 (14.8) 78 (10.6) 82 (11.3) 87 (12.3) 96 (12.5) 170 (0.9) 52 (9.4) 6 (3.8) 5 (3.5) 13 (7.2) 3 (2.0) 3 (2.0) 51 (7.8) 54 (7.9) 47 (7.8) 23 (7.6) 12 (4.5) 34 (9.9) 100 (10.9) 233 (14.3) 72 (9.8) 65 (8.9) 65 (9.2) 64 (8.4) 18442 546 157 144 181 152 152 645 687 603 304 264 343 914 1,631 738 728 708 766 p-value - χ 2 =468 p<0.001 χ 2 =56 p<0.001 F=52 χ 2 =140 χ 2 =18 χ 2 =18 χ 2 =405 χ 2 =404 χ 2 =397 χ 2 =174 χ 2 =79 χ 2 =305 χ 2 =871 χ 2 =1,896 χ 2 =566 χ 2 =509 χ 2 =551 χ 2 =527 ๋กœ์ •ํ™•ํžˆ์ ์–ด์•ผํ•˜๋ฉฐ, ์‚ฌ์šฉ์ƒ์˜์ฃผ์˜์‚ฌํ•ญ์€์•Œ์•„๋ณด๊ธฐ์‰ฝ๋„๋ก๋ช…ํ™•ํ•˜๊ฒŒ๊ธฐ์žฌํ•˜์—ฌ์•ผํ•œ๋‹ค๊ณ ๋ช…์‹œํ•˜๊ณ ์žˆ์œผ๋‚˜๋ณธ์—ฐ๊ตฌ๋ฅผํ†ตํ•ด์ด์™€๊ฐ™์€๋ฒ•์ ๊ทœ์ •์ด์—ฌ์ „ํžˆ์„ ์–ธ์ ์˜๋ฏธ์—๊ทธ์น˜๊ณ ์žˆ์ง€์•Š์€์ง€์‚ดํŽด๋ณผํ•„์š”์„ฑ์ด์ œ๊ธฐ๋˜์—ˆ๋‹ค. ์ƒ๋Œ€์ ์œผ๋กœ์‰ฌ์šด์–ดํœ˜๋กœ๊ตฌ์„ฑ๋œ์†Œํ™”์ œ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์˜๊ฒฝ์šฐ์—๋„์‚ฌ์šฉ์–ดํœ˜์˜๊ฐœ์„ ํ•„์š”์„ฑ์€์‰ฝ๊ฒŒํ™•์ธํ• ์ˆ˜์žˆ์—ˆ๋‹ค. ์˜ˆ๋ฅผ๋“ค์–ด, ์†Œํ™”์ œ์˜์•ฝํ’ˆ์„ค๋ช…์„œ๋„ ๋ฐ€์ „ํ•˜๋‹ค, ์‹์ฒด ๋“ฑ๊ฐœ์„ ์ด๊ฐ€๋Šฅํ•œ์–ด๋ ค์šดํ•œ์ž์–ด๋ฅผ์—ฌ์ „ํžˆํฌํ•จํ•˜๊ณ ์žˆ์—ˆ๋‹ค. ์ด๋“ค๋‹จ์–ด๋ฅผ๊ฐ๊ฐ ์ƒˆ๊ฑฐ๋‚˜ํ๋ฅด์ง€์•Š๊ฒŒ๋งˆ๊ฐœ๋ฅผ๊ผญ๋ง‰์Œ, ๋จน์€์Œ์‹์ด์ž˜์†Œํ™”๋˜์ง€์•Š๋Š”๋ณ‘ ๋“ฑ ์œผ๋กœํ’€์–ด์„œํ‘œํ˜„ํ•˜๋Š”๊ฒƒ์ด์†Œ๋น„์ž์˜์ดํ•ด๋ฅผ๋•๋Š”๋ชฉ์ ์œผ๋กœ๋”์šฑ์ ํ•ฉํ• ๊ฒƒ์ด๋‹ค. ์ด์™€๊ด€๋ จํ•˜์—ฌ์‹์•ฝ์ฒ˜์—์„œ๋Š”์—ฐ๊ตฌ์šฉ์—ญ์‚ฌ์—…์„ํ†ตํ•ด์•Œ๊ธฐ์‰ฌ์šด์šฉ์–ด๋ฅผ๋ฐœ๊ตดํ•˜์—ฌ๊ณ ์‹œ๋ฅผํ†ตํ•ด์ œ์‹œํ•˜๊ณ ์žˆ๋‹ค. 17) ๊ทธ๋Ÿฌ๋‚˜๊ณ ์‹œ๋œ์•Œ๊ธฐ์‰ฌ์šด์šฉ์–ด๋Š”๊ธฐ์กด์˜์šฉ์–ด์™€๋ณ‘๊ธฐ๋ฅผํ• ์ˆ˜์žˆ๋„๋กํ—ˆ์šฉํ•œ๊ฒฐ๊ณผ, ์†Œ๋น„์ž์ค‘์‹ฌ์˜์ •๋ณด์ œ๊ณต์„์œ„ํ•ด์˜์•ฝํ’ˆ์„ค๋ช…์„œ๋ฅผ๊ทผ๋ณธ์ ์œผ๋กœ๊ฐœ์„ ํ•˜๊ธฐ๋ณด๋‹ค๋Š”๊ด„ํ˜ธ๋ฅผ์‚ฌ์šฉํ•˜์—ฌ๋™์ผ์˜๋ฏธ๋‹จ์–ด๋ฅผ๋ฐ˜๋ณตํ•จ์œผ๋กœ์จ๊ฐ€๋…๋ ฅ์„๋–จ์–ด๋œจ๋ฆฌ๊ณ ์ข์€ํ‘œ์‹œ๋ฉด์ ์„๋”์ข๊ฒŒ๋งŒ๋“œ๋Š”๊ฒฐ๊ณผ๋ฅผ์ดˆ๋ž˜ํ•˜๊ณ ์žˆ์„๋ฟ์ด๋ผ๋Š”์šฐ๋ ค์˜๋ชฉ์†Œ๋ฆฌ๊ฐ€๋Œ€๋‘๋˜๊ณ ์žˆ๋‹ค. 2)

32 / Korean J Clin Pharm, Vol. 25, No. 1, 2015 ์ผ๋ถ€ํ•œ์ž์–ด๋ฅผ์ˆ˜์ •ํ•œ๋‹ค๊ณ ํ•ด๋„, ์˜์•ฝํ’ˆ์„ค๋ช…์„œ์ „๋ฌธ์–ดํœ˜์˜๋Œ€๋ถ€๋ถ„์„์ฐจ์ง€ํ•˜๋Š”์˜์•ฝ์šฉ์–ด๋ฅผ์ผ๋ฐ˜์ธ๋ˆˆ๋†’์ด์—๋งž๋Š”์šฉ์–ด๋กœ๊ณ ์ณ์“ฐ๋Š”๊ฒƒ์€ํ˜„์‹ค์ ์œผ๋กœํ•œ๊ณ„๊ฐ€์žˆ๋‹ค. ์ผ๋ฐ˜์†Œ๋น„์ž๊ฐ€์–ด๋ ต๊ฒŒ๋Š๋ผ๋Š”๋Œ€๋ถ€๋ถ„์˜์งˆ๋ณ‘๋ช…์ด๋‚˜๋ฌผ์งˆ๋ช…์€๊ณ ์œ ์–ด์ธ๊นŒ๋‹ญ์—์‰ฌ์šด๋Œ€์ฒด์–ด๊ฐ€์—†๋Š”๊ฒƒ์ดํ˜„์‹ค์ด๋‹ค. 2) ์˜์•ฝํ’ˆ์„ค๋ช…์„œ์—๋‚˜์—ด๋˜์–ด์žˆ๋Š”์ „๋ฌธ์ ์ธ์ •๋ณด๋Š”์†Œ๋น„์ž๊ฐ€์ œ๊ณต๋œ์ •๋ณด๋ฅผ์ดํ•ดํ•˜๊ณ ์žํ•˜๋Š”๋™๊ธฐ๋ฅผ์ €ํ•˜์‹œํ‚ค๋ฏ€๋กœ, 18) ์ด์—๋Œ€ํ•œ๊ฐœ์„ ์ฑ…์„์‹œ๊ธ‰ํžˆ๋ชจ์ƒ‰ํ•ด์•ผํ• ํ•„์š”์„ฑ์ดํฌ๋‹ค. ์ด์ฃผ์ œ์—๋Œ€ํ•ด์„œ๋Š”๋‘๊ฐ€์ง€๋ฐฉํ–ฅ์˜๋…ธ๋ ฅ์ดํ•„์š”ํ• ๊ฒƒ์œผ๋กœ์ƒ๊ฐ๋œ๋‹ค. ์ฒซ์งธ, ์ „๋ฌธ์šฉ์–ด์˜ํ‘œ์ค€ํ™”๋ฅผ๋ชจ์ƒ‰ํ•ด๋ณผ์ˆ˜์žˆ๋‹ค. ์ฆ‰, ์™ธ๋ž˜์ „๋ฌธ์šฉ์–ด๋ฅผ์ˆœํ™”ํ•˜๊ณ ์ •๋น„ํ•˜๋Š”์ผ์„์ง€์†์ ์œผ๋กœ์ถ”์ง„ํ•˜๊ณ ์›ํ™œํ•œ์˜์‚ฌ์†Œํ†ต์„์œ„ํ•œ ์ „๋ฌธ์šฉ์–ด๊ด€๋ฆฌ์‹œ์Šคํ…œ ์„์šด์˜ํ•˜๋Š”๊ฒƒ๋“ฑ์„์ƒ๊ฐํ•ด๋ณผ์ˆ˜์žˆ๋‹ค. 1) ๋‘˜์งธ, ์ •๋น„๋œ์ „๋ฌธ์šฉ์–ด๋ฅผ๋ณด๊ธ‰ํ•˜์—ฌ์ผ๋ฐ˜์†Œ๋น„์ž์˜๊ฑด๊ฐ•์ •๋ณด์ดํ•ด๋Šฅ๋ ฅ์„๋†’์ด๊ธฐ์œ„ํ•œ์ฒด๊ณ„์ ๊ต์œกํ”„๋กœ๊ทธ๋žจ๊ฐœ๋ฐœ์ด๋ณ‘ํ–‰ํ•˜๋Š”๊ฒƒ์„๊ณ ๋ คํ• ํ•„์š”๋„์žˆ๋‹ค. 19) ์ผ๋ฐ˜์†Œ๋น„์ž์˜์˜์•ฝํ’ˆ์„ค๋ช…์„œํ™œ์šฉ๋„๋ฅผ๋†’์ด๊ธฐ์œ„ํ•œ๋…ธ๋ ฅ์˜์ผํ™˜์œผ๋กœ์œ ๋Ÿฝ์—ฐํ•ฉ๊ณผ์บ๋‚˜๋‹ค, ํ˜ธ์ฃผ๋“ฑ์—์„œ๋Š”์˜์•ฝํ’ˆ์‚ฌ์šฉ์„ค๋ช…์„œ๋ฅผ์ „๋ฌธ๊ฐ€์šฉ๊ณผ์ผ๋ฐ˜์†Œ๋น„์ž์šฉ์œผ๋กœ์ด์›ํ™”ํ•˜์˜€๊ณ , ํŠนํžˆ์บ๋‚˜๋‹ค์™€ํ˜ธ์ฃผ๋Š”์ผ๋ถ€์†Œ๋น„์ž์ž๊ฐ€์น˜๋ฃŒ์˜์•ฝํ’ˆ (over-the-counter, OTC) ์—๋Œ€ํ•ด์„œ๋Š”์†Œ๋น„์ž์šฉ๋งŒ์ž‘์„ฑํ•˜๊ณ ์žˆ๊ธฐ๋„ํ•˜๋‹ค. ๋ฐ˜๋ฉด, ๋ฏธ๊ตญ๊ณผ์ผ๋ณธ์—์„œ๋Š”์‚ฌ์šฉ์‹œํŠนํžˆ์ฃผ์˜๊ฐ€ํ•„์š”ํ•œ์˜์•ฝํ’ˆ๋ฐ๋‚ด์šฉ์„์ค‘์‹ฌ์œผ๋กœ์†Œ๋น„์ž์šฉ๊ฐ€์ด๋“œ๋ฅผ์ž‘์„ฑํ•˜๊ณ ์žˆ๋‹ค. 20) ๋‚˜์•„๊ฐ€์œ ๋Ÿฝ์—ฐํ•ฉ์—์„œ๋Š”์ผ๋ฐ˜์ธ์—์ œ๊ณต๋˜๋Š”์˜์•ฝํ’ˆ์„ค๋ช…์„œ์˜๊ฐ€๋…์„ฑ (Readability) ์„์ง์ ‘์ผ๋ฐ˜์ธ์„๋Œ€์ƒ์œผ๋กœ๊ฒ€์‚ฌํ•˜์—ฌ๊ฐœ์„ ํ• ๊ฒƒ์„๊ถŒ๊ณ ํ•˜๋Š”๊ฐ€์ด๋“œ๋ผ์ธ์„์ตœ์ดˆ๋กœ๋ฐœํ‘œํ•˜์˜€๊ณ ์ด์—๋Œ€ํ•œ์—ฐ๊ตฌ๋„ํ™œ๋ฐœํžˆ์ด๋ฃจ์–ด์ง€๊ณ ์žˆ๋‹ค. 21-23) ๋˜ํ•œ, ์ด๋ฅผ์ž„์ƒ์‹œํ—˜์˜ํ•œ๋‹จ๊ณ„๋กœ๊ฐ•์ œํ™”ํ•˜๋Š”๊ฒƒ์ดํ•„์š”ํ•˜๋‹ค๋Š”๊ฒฌํ•ด๊ฐ€์ œ์‹œ๋˜๊ณ ์žˆ๊ธฐ๋„ํ•˜๋‹ค. 24) ์šฐ๋ฆฌ๋‚˜๋ผ์—์„œ๋„์˜์•ฝํ’ˆ์„ค๋ช…์„œ์ด์›ํ™”์—๋Œ€ํ•œ๋ชฉ์†Œ๋ฆฌ๋Š”๊พธ์ค€ํžˆ์ œ๊ธฐ๋˜๊ณ ์žˆ์œผ๋‚˜ 2,20) ์›๊ฐ€์ƒ์Šน๊ณผํ˜„์‹ค์ ์ธ์ƒํ™ฉ์„๊ณ ๋ คํ•˜์—ฌ์•„์ง์‹คํ–‰๋˜์ง€๋ชปํ•˜๊ณ ์žˆ๋‹ค. ์ฐจ์„ ์œผ๋กœ์‹์•ฝ์ฒ˜์—์„œ๋Š”์†Œ๋น„์ž์šฉ์˜์•ฝํ’ˆ์•ˆ์ „์‚ฌ์šฉ๋งค๋‰ด์–ผ์„๋ชจ์•„๊ณต๊ฐœํ•˜๊ณ ์žˆ์œผ๋‚˜ 2015๋…„ 1์›”ํ˜„์žฌ๊ฒŒ์žฌ๋œ 30์ข…์ค‘์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ๊ณผ๊ด€๋ จ๋œ๋‚ด์šฉ์€์•„์„ธํŠธ์•„๋ฏธ๋…ธํŽœ 1์ข…, ๊ฐ๊ธฐ์•ฝ 2์ข…๋“ฑ 3์ข…์—๋ถˆ๊ณผํ•œ์‹ค์ •์ด๋‹ค. ๋”์šฑ์ด๊ฐ๊ธฐ์•ฝ 2์ข…์˜๊ฒฝ์šฐ๋Š”๊ฐ๊ธฐ๋ผ๋Š”์งˆ๋ณ‘์—๋Œ€ํ•œ์ผ๋ฐ˜์ ์ธ์„ค๋ช…๊ณผ๊ฐ๊ธฐ์•ฝ์ „๋ฐ˜์—๋Œ€ํ•œ๋ณต์•ฝ์„ค๋ช…์—ํ•ด๋‹นํ•˜๋Š”๋‚ด์šฉ์ด๋ฏ€๋กœ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ๋ณต์šฉ์—์ง์ ‘๋„์›€์ด๋ ๊ฒƒ์ธ์ง€๋Š”๋ฏธ์ง€์ˆ˜์ด๋‹ค. ๋˜ํ•œ, ์ด์™€๊ฐ™์€์ •๋ณด๋ฅผ์ œ๊ณตํ•˜๊ณ ์žˆ๋Š” ์˜จ๋ผ์ธ์˜์•ฝ๋„์„œ๊ด€ (http://drug.mfds.go.kr) ์—๋Œ€ํ•œ์†Œ๋น„์ž์˜์ด์šฉ๋ฅ ์ด 10% ๋ฏธ๋งŒ์œผ๋กœ๋งค์šฐ์ €์กฐํ•œ๊ฒƒ 25) ์œผ๋กœ๋ณด๊ณ ๋˜๊ณ ์žˆ์–ด๊ทธํšจ์šฉ์„ฑ์—๋Œ€ํ•œ์šฐ๋ ค๊ฐ€ํฌ๋‹ค์šฐ๋ ค๊ฐ€ํฌ๋‹ค. ๋ณธ์—ฐ๊ตฌ์˜๊ฒฐ๊ณผ๋ฅผํ•ด์„ํ•จ์—์žˆ์–ด์„œ๋Š”๋‹ค์Œ๊ณผ๊ฐ™์€ํ•œ๊ณ„๋ฅผ๊ณ ๋ คํ•จ์ดํ•„์š”ํ•˜๋‹ค. ๋ณธ์—ฐ๊ตฌ๋Š”์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์˜์•ฝํ’ˆ์„ค๋ช…์„œ์˜์ดํ•ด๋„๋ฅผ์‚ฌ์šฉ๋œ์–ดํœ˜์˜๋‚œ์ด๋„์—๊ทผ๊ฑฐํ•˜์—ฌ์˜ˆ์ธกํ•œ๊ฒƒ์ด๋ฏ€๋กœ์‹ค์ œ์†Œ๋น„์ž์˜์ดํ•ด๋„์™€์ฐจ์ด๊ฐ€์žˆ์„์ˆ˜์žˆ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜, ์ด๋ฏธ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์ œ๋„๊ฐ€์‹ค์‹œ๋˜๊ณ ์žˆ์–ด์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ 13์ข… ์˜์•ฝํ’ˆ์„ค๋ช…์„œ๊ฐ€์ œ๊ณตํ•˜๋Š”์ •๋ณด์—๋Œ€ํ•œํ‰๊ฐ€๊ฐ€์‹œ๊ธ‰ํ•จ์„๊ณ ๋ คํ• ๋•Œ์ด๋Š”๋ณธ์—ฐ๊ตฌ์ž์—๊ฒŒ๋ถˆ๊ฐ€ํ”ผํ•œ์„ ํƒ์ด์—ˆ์Œ์„๋ฐํžŒ๋‹ค. ๋‘˜์งธ, ๋ณธ์—ฐ๊ตฌ์—์„œ๋Š”์–ดํœ˜๋ถ„์„๋ฐฉ๋ฒ•์˜๋™์ผ์„ฑ์„๊ฐ์•ˆํ•˜์—ฌ์ดˆ๋“ฑ 6 ํ•™๋…„๊ตญ์–ด๊ต๊ณผ์„œ๋ฅผ๋น„๊ต๋Œ€์ƒ์œผ๋กœ์„ ์ •ํ•˜์˜€์œผ๋‚˜, ์˜์•ฝํ’ˆ์„ค๋ช…์„œ๋‚ด์šฉ์˜ํŠน์„ฑ์ƒ์‚ฌํšŒ๊ต๊ณผ์„œ๋˜๋Š”๊ณผํ•™๊ต๊ณผ์„œ๊ฐ€๋ณด๋‹ค์ ํ•ฉํ•œ๋น„๊ต๋Œ€์ƒ์ด๋ ์ˆ˜์žˆ์Œ์„๋ฐํžŒ๋‹ค. ๋ณธ์—ฐ๊ตฌ์˜๊ฒฐ๊ณผ๋Š”์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์—๋Œ€ํ•ด์†Œ๋น„์ž์˜์•ˆ์ „ํ•œ์˜์•ฝํ’ˆ์‚ฌ์šฉ์„์œ„ํ•œ์ •๋ณด์ œ๊ณต์ด์ ์ ˆํžˆ์ด๋ฃจ์–ด์ง€๊ณ ์žˆ๋Š”์ง€์ ๊ฒ€ํ• ํ•„์š”์„ฑ์„์ œ๊ธฐํ•˜๊ณ ์žˆ๋‹ค. ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์˜ํŽธ์˜์ ํŒ๋งค๊ฐ€์‹œํ–‰ 2๋…„์ด์ง€๋‚œ๊ฒƒ์„์ƒ๊ฐํ•˜๋ฉด์ด๋Š”๋”๋ฏธ๋ฃฐ์ˆ˜์—†๋Š”์‹œ๊ธ‰์„ฑ์„๋‚ดํฌํ•˜๊ณ ์žˆ๋‹ค. ๋ณธ์—ฐ๊ตฌ๋ฅผ์‹œ์ž‘์œผ๋กœ๊ฐ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์˜์•ฝํ’ˆ์„ค๋ช…์„œ์—๋Œ€ํ•œ๋Œ€์†Œ๋น„์ž๊ฐ€๋…์„ฑ๊ฒ€์‚ฌ์™€ํ•ด๋‹น๊ฒ€์‚ฌ๊ฒฐ๊ณผ๋ฅผ๋ฐ”ํƒ•์œผ๋กœํ•œ์†Œ๋น„์ž์šฉ์˜์•ฝํ’ˆ์„ค๋ช…์„œ๊ฐœ๋ฐœ์ด์ด์–ด์ ธ์•ˆ์ „ํ•œ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์‚ฌ์šฉ์˜๊ธฐํ‹€์„๋งˆ๋ จํ•˜๊ธฐ๋ฅผ๊ธฐ๋Œ€ํ•˜๋Š”๋ฐ”์ด๋‹ค. ํŠนํžˆ, ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์ค‘์—์„œ๋„ํ•ด์—ด์ง„ํ†ต์ œ์™€์ข…ํ•ฉ๊ฐ๊ธฐ์•ฝ์—๋Œ€ํ•œ์†Œ๋น„์ž์šฉ์ •๋ณด์ œ๊ณต์ด๋ณด๋‹ค์‹œ๊ธ‰ํ•˜๋‹ค๊ณ ํ• ๊ฒƒ์ด๋‹ค. ๋‚˜์•„๊ฐ€, ํ•ด์—ด์ง„ํ†ต์ œ์™€๊ฐ™์ด์ถฉ๋ถ„ํžˆ๋‚ด์šฉ์ด๊ธด์˜์•ฝํ’ˆ์„ค๋ช…์„œ๋ฅผํ™œ์šฉํ•˜์—ฌ์„ค๋ช…์„œ์˜๋‚ด์šฉ์„์ƒ์„ธํ•ญ๋ชฉ ( ์˜ˆ ; ํšจ๋Šฅํšจ๊ณผ, ์‚ฌ์šฉ์ƒ์ฃผ์˜์‚ฌํ•ญ ) ์œผ๋กœ์„ธ๋ถ„ํ•˜์—ฌ๋ณธ์—ฐ๊ตฌ์™€๊ฐ™์€๋ถ„์„์„์‹ค์‹œํ•จ์œผ๋กœ์จ์‹œ๊ธ‰ํžˆ์ˆ˜์ •์ดํ•„์š”ํ•œ๋ถ€๋ถ„์„๊ฒ€์ฆํ•ด๋ณผํ•„์š”์„ฑ์ด์žˆ๋‹ค. ๊ฐ์‚ฌ์˜๋ง์”€ ์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ 13์ข…์˜์˜์•ฝํ’ˆ์„ค๋ช…์„œ์—๋Œ€ํ•ด 1์ฐจ์ ์ธ์–ดํœ˜๋นˆ๋„๋ถ„์„์„๋„์™€์ฃผ์‹  ( ์ฃผ ) ๋‚ฑ๋ง์–ดํœ˜์ •๋ณด์ฒ˜๋ฆฌ์—ฐ๊ตฌ์†Œ์—๊ฐ์‚ฌ์˜๋ง์”€์„์ „ํ•ฉ๋‹ˆ๋‹ค. ์ฐธ๊ณ ๋ฌธํ—Œ 1. Kim CW, Suh H, Yoon JC, et al. National literacy survey. Seoul: The National Institute of The Korean Language, 2008. 2. Lee I-H, Lee HW, Je NK, et al. Assessment of readability and appropriate usability based on the product labelling of over-the-counter drugs in Korea. Yakhak Hoeji 2012;56(5):333-45. 3. Song Y-J, Yoo H-J. Exploring the standard and contents of drug labelling among Korea, China and Japan. Korean J Risk Manage 2010;6(2):139-62. 4. Kim EH, Bang JS. Changes in perception of consumers for non-prescription drug policy since sales begins at the outside of pharmacy. Korean J Clin Pharm 2014;24(3):183-92. 5. Ko SJ. 2.7-fold increase in side effects of acetaminophen during the recent 3 years. Doctor's news. 2014 October 10 2014. Available from: http://www.doctorsnews.co.kr/news/articleprint.html?idxno=99278 [accessed December 23, 2014] 6. Gunn VL, Taha SH, Liebelt EL, et al. Toxicity of over-the-counter cough and cold medications. Pediatrics 2001;108(3):E52. 7. Sheen CL, Dillon JF, Bateman DN, et al. Paracetamol toxicity: epidemiology, prevention and costs to the health-care system. QJM 2002;95(9):609-19. 8. Zarcadoolas C, Pleasant AF, Greer DS. Defining health literacy.

์•ฝ๊ตญ์™ธ์—์„œํŒ๋งค๋˜๋Š”์•ˆ์ „์ƒ๋น„์˜์•ฝํ’ˆ์„ค๋ช…์„œ์˜๋‚œ์ด๋„ํ‰๊ฐ€ / 33 Advancing health literacy: A framework for understanding and action. San Francisco, CA: Whiley, 2006;45-67. 9. U.S. Department of Health and Human Services OoDPaHP. National action plan to improve health literacy. Washington, DC: Author, 2010; 10. Safeer RS, Keenan J. Health literacy: the gap between physicians and patients. Am Fam Physician 2005;72(3):463-8. 11. Bazaldua OV, Kripalani S. Health literacy and medication use. In: DiPiro JT, Talbert RL, Yee GC, et al., eds. Pharmacotherapy: A pathophysiologic approach. 8th ed. Columbus, OH: McGraw-Hill Education, LLC., 2011;5-6. 12. Lee SY, Yoon KJ, Lee JA. Changes in utilization and perception of OTC medications before and after convenience stores selling. Seoul: Korea Institute for Health and Social Affairs, 2013. 13. Sohn S, Kwon K. Health right and labelling system of drugs for convenience store. Crisis and Emergency Management: Theory and Praxis 2014;10(8):99-117. 14. Health Literacy Innovations. National survey of Medicaid guidelines for heatlh literacy. Health Literacy Innovations, 2007. 15. Kim K. Korean vocabulary for education. Seoul: Pagijong press, 2003. 16. Natmal. Institute of Korean Vocabulary Classification. 2008. Available from: http://www.natmal.com/ [accessed February 27, 2015]. 17. Kwon KH. Pharmaceutical products: Consumer information must be provided in accord with the purposes of product. 2012. Available from: http://www.kfda.go.kr/webzine/201201/12jan/kfda/ibook43.html [accessed January 5, 2015]. 18. Nam SJ, Yoo HJ. Information on medication and consumer competency. Consumption Culture Study 2010;13(1):21-37. 19. Krypel LL. Constructing a self-care curriculum. Am J Pharm Educ 2006;70(6):140. 20. Park S, Park EJ, Chae SM. Comparative analysis of drug labeling. Health-welfare Policy Forum 2010;160:40-55. 21. Raynor DK, Knapp P, Silcock J, et al. "User-testing" as a method for testing the fitness-for-purpose of written medicine information. Patient Educ Couns 2011;83(3):404-10. 22. Brooke RE, Herbert NC, Isherwood S, et al. Balance appointment information leaflets: employing performance-based user-testing to improve understanding. Int J Audiol 2013;52 (3):162-8. 23. Knapp P, Raynor DK, Silcock J, et al. Can user testing of a clinical trial patient information sheet make it fit-for-purpose?--a randomized controlled trial. BMC Med 2011;9:89. 24. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database of Syst Rev 2008;2: CD000011. 25. Lee IH, Kye S, Lee S. Consumer perspectives and utilization of drug information in Korea. Korean J Clin Pharm 2013;23(4):334-43.